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Background:  HIV viral suppression reduces the likelihood of transmission to just 5%,1 
demonstrating the critical link between care and prevention, yet only 51% of people living 
with HIV (PLWH) were retained in care and 46% achieved viral suppression in the Houston 
area (2012), with the out-of-care (OOC) population increasing between 2008-2011.2,3   
Methods: Record-search investigations across HIV surveillance and care data systems 
determined if potentially OOC persons referred to the Houston Health Department (HHD) 
from 2013-2015 (N=1287) qualified for public health follow up. A portion were randomized 
to a non-intervention group (n=200) to assess the program effectiveness. Participants without 
a disposition (n=381) were assigned to a service linkage worker (SLW) for assistance with 
returning to care.  Multiple logistic regression assessed (1) differences between follow-up 
populations (2) associations of persons relinked to care (3) statistical yield of the SLW 
intervention. Firth’s penalized likelihood approach analyzed rare events where applicable.   
Results: The majority of PLWH presumed to be OOC failed to qualify for follow up 
primarily due to recent evidence of care (n=552, 67.3%) or having moved out of jurisdiction 
(OOJ) (n=131, 16.0%).  Participants referred by Disease Intervention Specialists (DIS) or 
Texas jurisdictional health departments (incoming OOJ) (aOR:4.057, CI: 2.270-4.250; 
referent: provider), the Enhanced HIV/AIDS Reporting System (eHARS) surveillance 
referral source (aOR:2.054, CI:1.590-2.653; referent: provider), and having had an 
unsuppressed viral load at last report (aOR:1.368, CI:1.058-1.769; referent: viral 
suppression) had greater odds of qualifying for follow up while persons diagnosed with HIV 
longer (aOR: 0.968, CI:0.950-0.986) had lower odds.  Even after exhausting HHD resources 
to identify persons for SL outreach (n=381, 35.1%), most persons were still unable to locate 
(n=157, 41.2%) and few relinked to care (n=31, 8.1%).  Of those located (n=193), the 
majority self-reported already being in care (n=90, 46.6%) or refused SLW services once 
successfully contacted (n=59, 30.6%).  DIS/incoming OOJ referral source (aOR:7.242, 
CI:2.603-20.343; referent: provider), surveillance referral source (aOR: 2.722, CI: 1.011-
7.186; referent: provider), and 7+ client phone calls (aOR: 3.879, CI: 1.359-12.770; referent: 
two or fewer) were significantly related with returning to care via SLW.  DIS/incoming OOJ 
referral source (aOR=3.489, CI:1.609-7.919; referent: provider) and 7+ client phone calls 
(aOR=2.341, CI: 1.130-5.003; referent: two or fewer) were associated with greater odds of 
successful SLW contact while persons with a last reported viral load that was unsuppressed 
(aOR:0.587, CI: 0.355-0.967; referent: viral suppression) and incrementally higher number of 
client field visits had lower odds [(three or more, aOR:0.017, CI:0.005-0.048; two, 
aOR:0.024, CI:0.007-0.065; one, aOR:0.074, CI: 0.022-0.0195) referent: zero].  Participants 
were about half as likely to return to care by an SLW vs. those who returned to care on their 
own (aOR: 0.459, CI:0.180-1.098), although results were insignificant (P-value=0.089). 
Conclusions:  HDs contribute key information about the OOC population, but these systems 
fall short in timeliness and completeness when it comes to producing the data needed to 
successfully contact and relink PLWH, requiring extensive resource management.  More 
information is needed about the reasons for falling OOC to better address their specific needs 
and the dynamics influencing the fluid nature of HIV care.
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BACKGROUND 
Literature Review  
Measuring patients’ engagement with HIV care is critically important to understanding 
the epidemiology of virus transmission and can identify gaps along the HIV spectrum of care, 
pinpointing key areas for impactful interventions.4,5  It has been estimated that 61.3% of all HIV 
transmissions in the United States result from behaviors of individuals who were once in care for 
their HIV infection but have left care.1  This is the result of individuals having elevated viral 
loads due to not being in care.  It has been shown that individuals with suppressed viral loads 
through antiretroviral treatment are just 5% as likely to transmit HIV as those with unsuppressed 
viral loads.1 A randomized-control trial showed that PLWH who were not receiving treatment for 
their HIV infection, and, therefore, did not have an undetectable viral loads were 20 times more 
likely to infect their partners.6  Consequently, finding and re-engaging out-of-care individuals 
with their providers is crucial to controlling the HIV epidemic.  
Unfortunately, not being engaged in care is a widespread problem as demonstrated in a 
study of over 100,000 HIV-infected individuals from 13 areas in the USA that documented 52% 
of people who were in HIV care at one point in time did not have more than one clinic visit for 
HIV care in a year.1  Federal guidelines define continuous retention in care as having 2 or more 
laboratory tests (e.g., CD4+ T-lymphocyte count or viral load result) at 3 or more months apart, 
and being in medical care is defined as having greater than 1 laboratory test within a defined 
year.7  National estimates indicate that only 66% of HIV-diagnosed individuals who were 
initially linked to care remain in HIV care, although these estimates vary widely. 8  A meta-
analysis of 28 studies showed that 41% of PLWH were no longer engaged in care, but this might 
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be an underestimate of the true number of out-of-care individuals because these data were based 
on cross-sectional studies while PLWH may enter and exit the care system several times over the 
course of their infection.9 In the state of Massachusetts, where healthcare access is considered 
near universal, and retention rates are considered the highest in the country at 95-99%, viral 
suppression was still lagging at 70%.10  These estimates were also based on a standard of care to 
start antiretroviral therapy, or ART, when the CD4+ T-lymphocyte count was below 350 
cells/µL with divided opinions on whether to start at higher levels.11  At the time, at least one 
expert group recommended that all PLWH should be offered ART regardless of their CD4+ T-
lymphocyte count, standards which have been recently incorporated in the most recent guidelines 
for the use of antiretroviral agents in adults and adolescents living with HIV by the U.S. 
Department of Health and Human Services.12,13 By this new standard, the percent of PLWH 
needing therapy and not being virally suppressed would be substantially higher.  Being out of 
care is not only a public health hazard but also results in poorer quality health and reduced 
chances of survival.1,6,14–17   
Determining who is out of care and how to locate them are the first steps to re-engage 
HIV-infected persons with medical care, thereby accomplishing reduction in HIV incidence and 
improvement of HIV-infected persons’ health.  Reaching this objective is not an easy task 
because people who have left care are often difficult to locate because they have moved out of 
the area, are incarcerated, have relocated within the area, have changed providers, or have 
died.1,6  In addition, there is no universal template for identifying, finding, and reaching out-of-
care persons because of variation in local data sources and data analysis capabilities. For 
example, when multiple data sources, sampling sources, and case investigation were utilized to 
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investigate estimates of the HIV Care Continuum in King County, WA researchers found higher 
estimates of HIV-positive persons linked to care, retained in care, and virally suppressed, with 
almost twice the national estimates of viral suppression obtained in their population.18  Similar 
investigations confirm these results, emphasizing that assumptions of patients’ out-of-care status 
are disproved by migration out of the service area, death, or incarceration.18,19  These studies 
demonstrate that multiple methods and data system investigations are needed to determine care 
status, most of them adapted to the specialized systems at each locality but there is no universal 
standard. 
By Texas law, all laboratory tests that measure CD4+ T-lymphocyte counts and HIV viral 
load results must be reported to the Department of State Health Department (DSHS), and these 
results are made available to local health departments.20  Performance of these tests at every 
routine HIV clinical visit constitutes absolute minimum standard of care for HIV-infected 
patients which should be performed every 3 months.20  Therefore, any patient who has not had 
these tests in over a 6-month period may not be in care.  However, laboratory surveillance 
systems have also been found to be inefficient ways to determine who is out of care. A study that 
used a single, national system of laboratory results to identify potentially out-of-care individuals 
found that only 65% of eligible participants qualified for public health outreach, which included 
a phone call and/or mailed letter before scheduling a baseline interview to subsequently offer 
referral to a coordinated program offering comprehensive linkage to care, navigation, and partner 
services, indicating that single data sources inadequately inform assessments of care status.21  Of 
the 282 cases selected for follow-up investigation, 107 required enhanced searches of local 
databases for updated contact information, but, despite these efforts, 28% could not be located, 
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17% were located but had moved out of the jurisdiction, 1% were ineligible, and 2% were 
deceased.21  Consequently, valuable resources were spent pursuing persons with neither the need 
nor the eligibility for relinkage services, highlighting the necessity of more rigorous investigation 
of available records across multiple types of data systems to improve data integrity.  These 
investigations can also help determine if there are any sociodemographic predictors of 
engagement or gaps in care.  However, record searches and data extraction also require valuable 
time and training, so determining which data systems produce the most valuable information is 
needed. It is also possible that the potential of laboratory and care data systems for producing the 
most relevant care information differs, highlighting a gap in research knowledge.   
HIV Care Continuum 
Engagement with medical care is fluid, with patients filtering in and out of care 
throughout their lifetime.  Certain factors affect persons’ willingness to stay in care or return to 
care, and Health Departments represent a unique opportunity to engage with individuals in their 
jurisdiction throughout their journey over the entire HIV Care Continuum although it is 
necessary to consider other factors that impact this Continuum, such as migration.22  Their access 
to comprehensive reporting data and unique relationships with HIV-care providers allows for the 
design of outreach programs that are unique to the populations needing the most assistance with 
navigating the medical system.  
This continuum of care is a useful assessment of the HIV epidemic response developed in 
recent years.  Also known as the treatment cascade, it serves as a visual representation of the 
marked stages of HIV diagnosis and care that can help identify gaps for HIV prevention and 
treatment among populations of interest. One of the first Houston Treatment Cascades was 
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published in 2012 for the Houston Eligible Metropolitan Area (EMA) and measured five critical 
points: HIV infected, HIV diagnosed, in HIV care, retained in HIV care, and suppressed viral 
load.3  With the ultimate goal of reducing the number of new infections to zero, researchers and 
public health officials have recognized that an HIV-infected person must first know they are 
infected to begin treatment, and, once in treatment, must access ART and adhere properly to their 
medical regimen to obtain and sustain viral suppression. 
 
Figure 1. Houston EMA HIV Treatment Cascade  
 
Figure 1 includes data reflecting the overall EMA, number and percent of people with HIV in selected stages of the continuum of HIV care, 
2012
3
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Upon release of the first Houston Treatment Cascade, the difficulty in retaining these 
persons in care for uninterrupted access to ART was recognized, particularly noting that 
retention and viral suppression varied across subgroups.  In 2012, White (52%) and Hispanic 
(53%) were more likely to be retained in care compared to Black/African American (48%), and 
Black/African American were also least likely to be virally suppressed.3  Men who have sex with 
men (MSM) was the risk group that was least likely to be retained in care, and, among age 
groups, retention in care was lowest among youth (aged 13 to 24) and young adults (aged 25-34), 
each at 54%, as well as older PLWH (aged 65+) at 53%.3 
Following national guidelines calling for a new practice known as Treatment as 
Prevention (TasP), the HHD launched an initiative to relink HIV-positive persons, who were 
once in care but had recently fallen out of care, to an HIV care provider.  To optimize resources, 
multiple HIV surveillance and care data systems were utilized to record search potentially out-
of-care persons for recent evidence of an HIV care appointment and/or a CD4+ T-lymphocyte 
count and/or HIV viral load laboratory result.  These data systems were already in usage by 
various entities within the HHD but were never harnessed, particularly in conjunction with each 
other, for the purposes of identifying and/or confirming the current status of individuals 
potentially lost to care.  Other outcomes can be collected to reduce expenditure of outreach 
resources, such as recent death, incarceration, or relocation to another jurisdiction. The 
usefulness of each data system for producing accurate, comprehensive, and recent evidence of 
care is currently unknown, but this critical knowledge is needed to determine the best practices 
for measuring the out-of-care population. 
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These data systems, and quantifying their utility, are also necessary to maximize the 
effectiveness of the SLW program.  Once a record was searched and the person deemed likely to 
be out of care, any relevant locating information was extracted from the data systems and 
referred to an SLW who would subsequently attempt to locate the person and relink them to 
medical care.  Once a person is in care, not only is their quality of life improved, but they are 
highly unlikely to transmit the virus to others because regular visits with a physician, who can 
prescribe and monitor ART, can reduce a patient’s viral load to undetectable levels.  However, 
the yield, that is, how many additional persons are relinked to care due to SLW interactions, of 
the relinkage program has not been established.  The number of referrals successfully relinked to 
HIV care or ancillary services to support their care, in addition to the challenges of initially 
contacting and locating these clients based on surveillance and care data, is unknown.   Research 
is needed to determine the effectiveness of the SLW program to establish the next steps for 
expanding TasP among the populations most in need of the HHD services. 
Persons determined to be out of care were counseled by an SLW on the importance of 
returning and remaining in care and assisted in overcoming any barriers that prevented them 
from returning to care.  Research has demonstrated that barriers to retention in care for HIV-
positive persons include the following:  competing life activities, feeling sick, stigma, depression 
and mental illness, expensive and unreliable transportation, insufficient health insurance, 
forgetfulness, substance abuse, negative experiences with clinic space and processes, challenges 
with appointment scheduling, difficult relationships with clinic staff including providers, and/or 
inconsistent or unstable or inadequate housing.23,24  In one study, participants reported an 
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average of 3 barriers to retention in care, indicating that assistance in navigating the healthcare 
system and overcoming hurdles to HIV care is complex.23   
Service Linkage Program 
The HHD identified potential ways, considered referral sources (Study Subjects), for 
identifying HIV-infected individuals who have left medical care.  Furthermore, there were eight 
online data systems involved with collecting locating and contact information in addition to 
recent evidence of care so that SLWs could assist these persons with returning to care.  
Contacting individuals regarding their HIV infection status is a traditional role of health 
departments.  Employees of the HHD are permitted, by Texas law, to contact any person who is 
potentially at risk of transmitting a sexually transmitted disease to connect those persons with 
treatments that will prevent further transmission of the disease.  Contacting of HIV-infected 
persons is fully permissible by law.   
The traditional role of the SL program is initial linkage to care following an HIV 
diagnosis, established in 2008 at the HHD.  Linkage-to-care rates within one year of receipt of 
diagnosis are high, with most new diagnoses linked to a medical community within 12 months 
(>80%).25 However, once a patient is established in a medical home, the traditional role of 
sustaining care has been considered the role of the provider.  Upon development of the first HIV 
Care Continuum, the large discrepancy between initial linkage to care and remaining in care was 
demonstrated as a significant public health problem, both for care and prevention stakeholders. 
Primary data analysis indicated that people were not in care, but, once they removed themselves 
from a medical network, their last primary care facility had limited information and resources to 
find and re-engage them, and there was no public health safety net to catch these individuals.   
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The SL Program was originally designed to accept referrals from persons recently active 
in a pre-existing public health network because of a new diagnosis.  Those referrals must have 
been tested recently, therefore they had been in contact with either a laboratory or a provider or a 
testing program of some sort; therefore, presumably, they were within the SLW’s local 
jurisdiction and likely shared viable locating information and communicated other facts about 
their status that is vitally important to an SLW successfully managing their case.  For persons 
lost to care, there is likely sparse, outdated information and no active data.  Consequently, the 
purposes of this study were to create a method of identifying persons who were potentially out of 
care, utilize all potential data systems to confirm this out-of-care status while simultaneously 
collecting as much contact information as possible, then determine if the SLW’s skills of initial 
linkage to care were transferable and adaptable to relinking persons to care.   
 Therefore, SLWs are individuals who can contact HIV-infected persons who are not 
receiving medical care, facilitate the return of these person to care, and work to keep these 
persons in care once they have re-engaged with the medical system.  A subgroup of this 
population was randomized to a non-intervention arm (see Study Design), which would not 
receive the SLW intervention, for comparison to a subgroup of SLW-eligible individuals.  
Randomly assigning some individuals to receiving the services of SLWs and others to not 
receiving these services is ethical because the demand for the services of SLWs for relinkage to 
care far exceeds the available resources.  With or without this random assignment, most persons 
who are out of care will not receive these services.   
The basic process for SLW assignment after the initial surveillance investigation among 
online data systems involves a supervisor.  The SLW supervisor would make the initial phone 
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contact with the HIV-infected individuals and subsequently assigned these persons to an SLW.  
The SLW would then schedule and meet with the clients to provide non-medical case 
management within a 90-day period, based on the Ryan White Grant Administration’s (RWGA) 
Standards of Care (SOC).  The SOC are created by the Houston Eligible Metropolitan Area 
(EMA) RWGA and are based on multiple sources, including RWGA program monitoring results, 
consumer input, the US Public Services guidelines, Centers for Medicare and Medicaid 
Conditions of Participation (COP) for healthcare facilities, JCAHO accreditation standards, the 
Texas Administrative Code, Center for Substance Abuse and Treatment (CSAT) guidelines, and 
other federal, state, and local regulations.26  The HHD receives funding from multiple source, 
including the RWGA, for various service linkage activities but adheres to these SOC to achieve 
program goals, grant deliverables, and full compliance.  The supervisor can determine if 
additional time to relink the person to care is feasible and necessary based on the unique needs of 
the client.  The SLWs would travel throughout the city to meet with out-of-care persons in 
environments fitting their comfort and assess their clients’ willingness to return to care and the 
barriers that prevent them from seeking care.  They would assist the clients in making 
appointments, both medical and non-medical, and help find the resources that would enable them 
to re-establish and remain in care.  The SLW could assist with linkage to the following range of 
services:  primary medical care, abuse history or domestic violence, adherence to treatment, 
dental, foster care or adoption, functional or homecare, general education, health insurance, 
hearing, HIV education, hospice care, housing, legal, mental health, nutritional supplements or 
food pantry, pain management, prescription assistance, rental or utility assistance, safer sex or 
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family planning, substance abuse counseling, support system, transportation, vaccination, and 
vision. 
Houston/Harris County HIV Epidemic 
In the Houston/Harris County area, 22,551 people were living with HIV as of 2013; 
49.6% were Black/African American and 49.2% were aged 45 years and older.27  Most of Harris 
County encompasses Houston city limits but not all.  The total number of PLWH increased to 
26,041 before 2016, the 11th highest rate of new HIV diagnoses in the nation, with the largest 
risk category among MSM who account for the largest percent of new diagnoses at 90%.27,28 
Gaps in Knowledge 
SLWs are a more recent addition to the workforce and their utility has not been fully 
evaluated.  Studies are needed to demonstrate the capacity of SLWs in relinking HIV-infected 
individuals to medical care.  However, persons who drop out of care might return to care of their 
own volition, although the length of time can vary greatly.  The marginal contribution of the 
SLWs for relinking patients to care is unknown.  Furthermore, an assessment of surveillance data 
has not been done to determine if surveillance reporting have any measurable impact on the 
ability of health departments to identify and successfully relink out-of-care, HIV-positive 
persons to a medical provider.   
Public Health Significance 
The proposed study helped fill a major gap in knowledge about the potential application 
of HIV surveillance and care data for identifying and relinking out-of-care persons to medical 
services in the Houston/Harris County area.  It contributed knowledge about whether 
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surveillance and care data systems produced wide variations in data quality and helped determine 
the eventual outcomes of using HIV data for relinking persons to care.  Additionally, it assessed 
the marginal contribution of SLWs.   
The results of this study also determined if possible differences between populations who 
might be out of care and those who are confirmed as currently out of care among multiple data 
systems.  Additionally, it explored any predictors of successful relinkage to care by the SLW 
Program.  Surveillance investigation and the SLW intervention are resource intensive and require 
significant manpower.  Quantifying their impact and determining if certain differences exist 
between the populations served by this study can help prioritize future referrals to those most in 
need of assistance, thereby funneling finite resources for maximum impact. 
Hypothesis, Research Question, Specific Aims or Objectives 
Surveillance investigation across multiple data systems was expected to reduce the 
number of potentially out-of-care referrals to those individuals most likely to truly be out of care 
and in need of relinkage services because it eliminated subjects with other outcomes.  For 
instance, a person who is deceased would not benefit from SLW services, nor would local 
Houston resources be useful to someone living outside of city limits.  However, only the health 
department has the capacity to measure these outcomes given their access to myriad record 
sources.  By identifying the data systems’ ability to correctly assign outcomes for service linkage 
activities, finite resources are maximized to best serve the populations most in need of relinkage.  
Persons qualifying for SLW intervention are expected to have greater odds of returning to care 
compared to those individuals in the non-intervention subgroup. 
A.1. Specific Aim 1  
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Aim 1 will employ cross-sectional analyses to assess significant differences between 
participants who qualified for follow up based on surveillance investigation outcomes and those 
who did not. Covariates of interest are birth sex, race, ethnicity, the most recent CD4+ T-
lymphocyte count test result, the most recent viral load test result, age, referral source, and the 
time since HIV diagnosis.  
A.1.a. Research Questions for Specific Aim 1 
 
Table 1. Research Questions for First Aim 
Question Data Type Analysis/Output 
What databases were used for 
record searches, and what 
information did each system 
provide? 
Narrative N/A 
What were the outcomes of the 
databases searches (i.e., how many 
referrals were administratively 
closed and why?) 
Descriptive Number/Percent 
What databases had the most 
recent evidence of care? 
Descriptive Number/Percent 
Which care or surveillance data 
system produced evidence of care 
in the most referrals? 
Descriptive Number/Percent 
After record searches, what are the 
demographics of the assigned 
referrals versus those that are 
administratively closed? 
Descriptive/Inferential Number/Percent; t-test, chi square 
Were there any significant 
predictors, such as referral sources 
or sociodemographic 
characteristics (see Table 3) of 
being classified as potentially out 
of care (per database disposition)? 
Inferential Logistic Regression 
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A.1.b. List of Variables 
 
Table 2. Variables for First Aim 
Variable Data Type 
Age Categorical 
Sex Categorical 
Race Categorical 
Ethnicity Categorical (binary) 
Referral Source Categorical 
Time since HIV diagnosis  Continuous 
Database name Categorical 
Time since last care date Continuous 
Most recent CD4+ T-lymphocyte count Continuous, Categorical (binary) 
Most recent Viral Load Continuous, Categorical (binary) 
 
A.1.c. List of Outcomes 
 
Table 3. Outcomes for First Aim 
Outcomes 
Assigned (to SLW) 
Evidence of Care 
Incarcerated 
Deceased 
Out of Jurisdiction (OOJ) 
Ineligible 
Ineligible includes pregnancy, under the age of 18, newly diagnosed with HIV,  or lacking evidence of ever having been in HIV care 
 
A.2. Specific Aim 2  
 
Aim 2 will employ cross-sectional analyses to investigate potential associations of 
successful relinkage to care through SLW assistance for those who were confirmed as out of care 
from surveillance investigation.  Possible differences between those successfully relinked and 
those who were not relinked to care might identify sub-populations with additional barriers to 
care and in need of further investigation to improve healthcare access.  Quantifying the difficulty 
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of contacting and relinking these people to care also emphasizes the need for optimal data 
collection through the utilization of multiple data sources to reduce wasted resources. 
A.2.a Research Questions for Specific Aim 2 
 
Table 4. Research Questions for Second Aim 
Question Data Type Analysis/Output 
What were the outcomes of all 
referrals sent to SLWs 
Descriptive Number/Percent 
What was the mean number of 
days from the first contact by 
SLW to the intake?  From intake 
to relinkage? 
Descriptive Mean, Median, Mode 
Which referral source was 
associated with the highest SLW 
relinkage 
Descriptive N/A 
What were the top reported 
reasons for falling out of care for 
those successfully contacted by 
the SLW? 
Descriptive Number/Percent 
What were the resources 
exhausted for those referred to 
SLWs (number of contacts)? 
Descriptive Mean, Median, Mode 
Were there any significant 
predictors, such as demographics 
or referral source or worker 
contact, of outcomes (relinkage to 
care via SLW outreach)? 
Inferential Logistic Regression 
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B.2.b. List of Variables 
 
Table 5. Variables for Second Aim 
Variable Data Type 
Data System Results  
Age Categorical 
Sex Categorical 
Race Categorical 
Ethnicity Categorical 
Referral Source Categorical 
Time since HIV diagnosis  Continuous 
Most recent CD4+ T-lymphocyte count Continuous, Categorical 
Most recent Viral Load Continuous, Categorical 
Intervention Results  
Reason for Being Out of Care Categorical 
Days (received-intake date) Continuous 
Days (intake date-medical appointment date) Continuous 
Number of Phone Calls to Provider Continuous 
Number of Field Visits to Provider Continuous 
Number of Phone Calls to Patient Continuous 
Number of Field Visits to Patient Continuous 
 
Phone calls to providers or to patients were unlimited units, but there was an upper limit 
of 8 field visits per provider and per patient. 
A.2.c. List of Outcomes 
 
Table 6. Outcomes for Second Aim 
Outcomes 
Relinked to care 
Incarcerated 
Deceased 
Already in care 
OOJ 
Refused services  
Unable to locate 
Other 
Ineligible includes pregnancy, under the age of 18, newly diagnosed with HIV, or lacking evidence of ever having been in HIV care 
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A.3. Specific Aim 3 
 
Aim 3 is an experimental design that will determine if intervention subgroup members 
were more likely to return to care compared to the non-intervention subgroup members. 
Quantifying the ability of SLWs to successfully return participants to care can be used for 
programmatic planning purposes.   
Potentially out-of-care persons were randomized as 200 intervention subjects and 200 
non-intervention subjects from the eHARS surveillance referral mechanism, so this 
subpopulation can be used to assess the marginal contribution (yield) of the SLWs in assisting 
patients with returning to care.  The non-intervention subgroup was not assigned to an SLW, 
regardless of whether surveillance investigation determined a person was truly out-of-care.  
Instead, after the initial investigation, a second record search was conducted 90 days later to 
determine if the person returned to care on their own (Figure 3).  This time period was equivalent 
to when a truly out-of-care referral would have been assigned for follow up with an SLW.     
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A.3.a. Research Questions for Specific Aim 3 
 
Table 7. Research Questions for Third Aim 
Question Data Type Analysis/Output 
What were the outcomes of the 
intervention subjects sent to the 
SLWs  
Descriptive Number/Percent 
What were the outcomes of the 
non-intervention subjects who 
qualified for 90-day follow up? 
Descriptive  Number/Percent 
What was the mean number of 
days for the intervention subjects 
from the first contact by SLW to 
the intake?  From intake to 
relinkage?  
Descriptive Mean, Median, Mode 
What was the mean number of 
days from the date of second 
Surveillance Investigation 
initiation to the date the non-
intervention subjects returned to 
care on their own among the 90-
day follow up? 
Descriptive Mean, Median, Mode 
What were the top reported 
reasons for falling out of care for 
intervention subjects successfully 
contacted by the SLW? 
Descriptive Number/Percent 
What were the resources 
exhausted for intervention 
subjects referred to SLWs? 
Descriptive Mean, Median, Mode 
Were there any significant 
predictors, such as demographics 
or worker contact, of outcomes 
(relinkage to care via SLW 
outreach)? 
Inferential Logistic Regression 
Randomized Subgroup - After the 
90 day follow up, what was the 
care status of intervention subjects 
versus non-intervention subjects?   
Descriptive/Inferential Number/Percent, significant 
differences to be assessed 
inferentially 
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A.3.b. List of Variables 
 
Table 8. Variables for Third Aim 
Variable Data Type 
Data System Results  
Age Categorical 
Sex Categorical 
Race Categorical 
Ethnicity Categorical 
Referral Source Categorical 
Time since HIV diagnosis  Continuous 
Most recent CD4+ T-lymphocyte count Continuous, Categorical 
Most recent Viral Load Continuous, Categorical 
Intervention Results  
Reason for Refused Services  Categorical 
Reason for Being out of Care Categorical 
Days (received-intake date) Continuous 
Days (intake date-medical appointment date) Continuous 
Number of Phone Calls to Provider Continuous 
Number of Field Visits to Provider Continuous 
Number of Phone Calls to Patient Continuous 
Number of Field Visits to Patient Continuous 
 
A.3.c. List of Outcomes 
 
Table 9. Outcomes for Third Aim 
Outcomes for Non-intervention Outcomes for 
Intervention  
Assigned (to SLW) Relinked to care 
Evidence of Care Incarcerated 
Incarcerated Deceased 
Deceased Already in care 
Out of Jurisdiction (OOJ) OOJ 
 Refused services 
Unable to locate 
Other 
Ineligible includes pregnancy, under the age of 18, newly diagnosed with HIV, or lacking evidence of ever having been in HIV care 
 
METHODS 
Study Setting 
Houston is the fourth largest city in the United States and is the county seat of Harris 
County. The County has approximately 4.5 million residents.   It is one of the most diverse areas 
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in the United States with a population of 30.4% non-Hispanic white, 42.4% Hispanic, 19.7% 
African-American, and 7.2% Asian.29 One-quarter of the population is foreign born and 43.4% 
of the population speaks a language other than English at home.29  As of 2012, there were 
approximately 23,000 PLWH in Houston/Harris County and about 30% of those who were once 
in care were currently out of care.30  An estimated 74.1% of PLWH were male, 49.8% were 
Black/African American, and 31.7% were aged 45-54, with the highest transmission risk among 
MSM (51.3%).30 
Study Design 
A cohort (N=1287) of potentially out-of-care PLWH in the Houston/Harris County area 
was selected from various referral sources (see Data Collection) from 20 June 2013 through 14 
July 2015.  Online records were reviewed among eight data systems to determine if 1087 of 
these referrals qualified for SLW intervention, and, subsequently, if qualified referrals were 
successfully relinked (i.e., attendance at an appointment with a medical provider) to HIV medical 
care.  Using simple randomization, a subgroup of these referrals (n=400) were randomly selected 
from the same referral source, eHARS (see Data Collection), and randomly assigned to an 
intervention arm (n=200) or non-intervention arm (n=200).  Analyses were restricted to living 
prevalent cases in City of Houston/Harris County who were 18+ years of age as allowed by 
governing public health policy. All CD4+ T-lymphocyte counts and viral load results with a 
valid month and year for specimen date were considered.  Anyone with a last known address 
outside of Houston/Harris was also excluded.   
The non-intervention subgroup did not receive the SLW intervention, but, if record 
searches in Data System Investigation A (see Figure 3) confirmed the non-intervention subject 
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was likely to be truly out of care, they received an additional surveillance investigation follow up 
among the same data systems at 90 days after the initial record search (Data System 
Investigation B, see Figure 3) to determine if they returned to care on their own in comparison to 
intervention subjects.  Three months is the usual timeframe for Ryan White service linkage, with 
a standard goal to close a case investigation by 90 days. Relinkage to care was modeled after RW 
service linkage; however, it was logistically easier to be granted an extension past 90 days for 
relinkage to care, which is a limitation of modeling a 90-day follow-up period for non-
intervention subjects. 
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Figure 2. Flowchart of Study Population 
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Data Description 
Criteria for referral: The study unit is PLWH who were located in the Houston/Harris 
County area during their last evidence of care but who lacked any evidence of care within the six 
months (183 days) or more prior to the date of referral to the HHD for surveillance investigation.   
Evidence of care from surveillance investigation (SI):  Evidence of care as determined 
during surveillance investigations was defined as a medical appointment completed with a 
healthcare provider for HIV-related follow up and/or a CD4+ T-lymphocyte count and/or viral 
load laboratory result within the six months prior to the date of surveillance investigation among 
online records, not the date the referral was received by the HHD.   
For the non-intervention subjects, 200 potentially out-of-care persons were investigated 
(Data System Investigation A) among online data systems for an outcome.  If no outcomes were 
found, the person was presumed to still be out of care.  Unlike the intervention subgroup, non-
intervention subjects lacking any outcome after the initial investigation (Stage A) were not 
assigned to the SL Program.  However, they were re-investigated (Data System Investigation B) 
among online data systems 90 days after the initial date of investigation (Date A).  The primary 
measure of interest was binary: Yes (the patient had any outcome within the previous 90 days, 
e.g., in care, out of jurisdiction, deceased, etc.) or No (the patient lacked any outcome so was 
presumed to still be out of care). 
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Figure 3. Non-intervention Subgroup - primary timeline of investigation with 90-day 
follow up 
 
 
Study Subjects 
The study investigated four sources of referrals of potentially out-of-care PLWH and 
assessed whether further investigation across multiple data systems confirmed that a referral 
truly appeared to be out-of-care or had evidence of other outcomes. 
Surveillance Referrals. Under Chapter 97 of Texas Administrative Code, all CD4+ T-
lymphocyte count and HIV viral load laboratory results are subject to required reporting to the 
local health authority.  In Houston/Harris County, the local health authority is the City of 
Houston Health Department. If individuals had at least one of these tests reported from 1 July 
2011 through 31 June 2012 in a surveillance database, eHARS, they were considered in care 
during this time period, arbitrarily defined in the beginning of the study.  It was assumed that 
having had more recent evidence of care, relative to falling out of care and qualifying for 
inclusion in this study, would adhere most closely to the HHD’s commitment to offer services as 
Referral Received
Variable: Date of Receipt
Referral Source: eHARS 
(Surveillance Linelist)
Data System Investigation (A)
Data System(s): All
Variable: Date of Surveillance 
Investigation (A)
Binary Outcome
• Yes: Outcome (e.g., evidence of care 
within the previous 183 days, 
incarcerated, deceased, etc.)
• No: Lacks an SI outcome so qualifies 
for additional follow up in 90 days (i.e., 
patient presumed to be out of care)
Data System Investigation (B)
Data System(s): All
Variable: Date of Surveillance 
Investigation (B)
Binary Outcome
• Yes: Outcome (e.g., evidence of care 
within the previous 90 days, 
incarcerated, deceased, etc.)
• No: Lacks an SI outcome so patient 
presumed to still be out of care
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soon as they are determined to be needed.  Laboratory records for these individuals were 
subsequently reviewed again from 1 July – 31 December 2012.  The second time period was 
selected because current recommendations state laboratory results should be performed every 3 - 
6 months, so missing these tests within the six months after a previous appointment were proxy 
indicators of missing care.  Over 6,000 persons were identified, a population substantially larger 
than available resources for subsequent investigation. Therefore, 200 intervention subgroup 
members were randomly selected for public health follow up to determine the utility of this 
source for locating out-of-care persons. These individuals were referred in one batch to 
surveillance investigation, and, due to limited personnel and staff time, only a few persons could 
be record searched per day resulting in a varied delay period.  
Provider Referrals.  Three HIV providers, funded by Harris County Public Health 
through the Ryan White Care act, transmitted lists of patients to the HHD of persons their 
respective systems deemed to have fallen out of care.  These providers included Harris Health 
System, St. Hope Foundation, and Houston Area Community Services.  Each of these 
organizations is required, as a condition of receiving funds from Houston’s Ryan White Grant 
Administration in the local area, to identify their patients who have seemingly dropped out of 
care.  They must attempt contact with each of these individuals three times by more than one 
method (e.g., phone, mail, email, text, home visit) to encourage them to return to care.  The HHD 
created Point-of-Entry agreements with each of these organizations in order to establish 
guidelines for sharing of client-level data in accordance with health authorities mission to control 
and treat communicable disease (Chapter 81 of the Texas Health and Safety Code).  These 
agreements made it possible for the HHD to obtain a list of potentially out-of-care individuals 
30 
 
from each provider. In total, 806 persons were referred by these providers.  These individuals 
were referred in batches to surveillance investigation, and due to limited personnel and staff 
time, only a few persons could be record searched per day resulting in a varied delay period. 
Disease Intervention Specialist (DIS) Referrals.  DISs are responsible for obtaining the 
names and contact information of the partners of persons diagnosed with sexually transmitted 
diseases (STD) and subsequently notifying and testing partners of possible exposure. This 
process, known as partner elicitation and notification, interrupts disease transmission in the 
community. In Houston/Harris County, DIS attempt to locate and interview all suspected cases 
of HIV and syphilis as part of the elicitation and notification process. Those already living with 
HIV who are pregnant or have a new reportable STD (chlamydia, gonorrhea, or syphilis) are also 
initiated for intervention. During an encounter with a newly STD-diagnosed patient or partner, a 
DIS might discover a previously diagnosed PLWH who reveals that he or she is no longer 
receiving HIV-related medical care. DIS referred 70 persons to this study.  DIS referrals were 
submitted individually and surveillance investigation was completed within 24 hours of receipt 
during business hours. 
Incoming Out of Jurisdiction (OOJ) Referrals. Migration is a major factor that impacts an 
individual’s ability to establish care efficiently and effectively.  State and/or local jurisdictions 
have routinely shared data so that health departments do not duplicate clients in surveillance 
records and so that they may share information to locate partners of newly diagnosed cases.  
More recently, some health departments have used this established communication pathway to 
also ensure that PLWH who have moved between jurisdictions receive assistance to navigate the 
local care system. 11 individuals were referred from this source.  OOJ referrals were submitted 
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individually and surveillance investigation was completed within 24 hours of receipt during 
business hours. 
All referrals were 18 years of age or older and not pregnant.  They had documented 
evidence of care through a medical record, provider account, confirmation from another health 
department, or CD4+ T-lymphocyte and/or viral load laboratory result at some previous point in 
time and had evidence of a positive HIV diagnosis.  
These referrals served as the starting point for determining who was actually out of care.  
Subsequent record searches across multiple care and surveillance data systems provided 
additional information on current care status and locating information.  If a referral had evidence 
of an attended medical appointment for HIV care or CD4+ T-lymphocyte or viral load laboratory 
results within the immediate six months prior to the investigation date, they were considered 
currently in care.  If available records confirmed a PLWH was likely to be out of care, they were 
assigned to an SLW.  SLWs are non-medical case managers who specialized in finding and 
facilitating HIV-positive clients’ return to care for this study intervention.  
 
Sample Size Calculation and/or Study Power 
Subgroup of Intervention and Non-Intervention Members 
 
Although literature is sparse given the lack of experimental designs to measure the impact of 
non-medical case managers on relinking HIV-positive persons to care, assuming the expected 
proportion of those unexposed to an SLW who return to care is 0.05, the expected proportion of 
those exposed to an SLW who relink to care is .15, a 95% confidence level, and a desired power 
of 0.80 (i.e., the percent chance of detection), the sample size per group should be 141 
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participants, and the total sample size should 282 participants at minimum.31   Exposure to a non-
medical case manager was defined as any initial attempt at contact by said worker, such as any 
phone call or mailed letter or home visit, etc.  The expected proportion of those exposed to an 
SLW who relink to care with an outcome was estimated from literature published closest to 
study initiation, ranging from 15-16% as reported by relinkage to care programs similar in design 
amongst urban populations.32,33  The proportion of unexposed with an outcome was unknown 
and informed by internal surveillance data. 
This method was used with the following formula, for the required sample size: 
 
𝑛′ = [
𝑧∝√𝑃0(1 − 𝑃0) + 𝑧𝛽√𝑃1(1 − 𝑃1)
𝑃1 − 𝑃0
]
2
 
 
According to Fleiss, Levin, and Paik (2003), 𝑧∝ is the “critical value of cutting off the probability 
alpha in the upper tail of the standard normal distribution,” (Chapter 2, Section 5) and 𝑧𝛽 is the 
“critical value of cutting off the probability beta in the upper tail of the standard normal 
distribution” (Chapter 2, Section 5).31   
 
𝑛 =
n′
4
 (1 + √1 +
2
n′|𝑃1 − 𝑃0|
)
2
 
 
Here, 𝑃1 is the estimated proportion relinked to care in the exposed, and 𝑃0 is the estimated 
proportion returned to care in the unexposed.31 
The resulting odds ratio would be 3.4 based on the contingency table below: 
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Data Collection 
Eight online data systems were record searched to gather information about each referral. 
Two of these systems serve as repositories of laboratory results while two others store medical 
care records.  The care and laboratory data systems provided recent evidence of care or 
confirmed that a referral was likely to be out of care, thus qualifying for SLW intervention.  All 
databases were used to collect client contact information and other identifying factors so there 
would be substantial evidence to verify that each person found in each system was the correct 
identity and to determine if the referral might be ineligible for relinkage services because of 
other outcomes (e.g., incarcerated, deceased, out of jurisdiction, or ineligible due to pregnancy, 
under the age of 18, newly diagnosed with HIV, or lacking evidence of ever having been in HIV 
care).  Persons who were 18 or pregnant were excluded for research purposes.  The outcome of 
interest was whether surveillance investigation produced evidence that a referral was currently in 
care or currently out of care.   
eHARS. Known as the Enhanced HIV/AIDS Reporting System, eHARS is a national 
HIV surveillance system that houses HIV testing results, patient demographics, and patient 
contact information. These data are imported or entered based upon reports from providers, 
laboratories, or other sources of HIV testing as required by Texas Administrative Code.  Aside 
from HIV diagnostic tests, reportable since 1999, CD4+ T-lymphocyte and viral load laboratory 
results have been mandatory since 2010,34 and these laboratory results can serve a proxy for the 
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most recent evidence of care.  The primary contribution of this system was HIV diagnostic and 
laboratory measures of care. 
Maven. This software is a customizable disease surveillance and case management 
system. The HHD’s Maven system, Houston Electronic Disease Surveillance System (HEDSS), 
includes a module that serves as a repository for electronic laboratory reports of HIV.  It collects 
and houses results from commercial, state, and local hospital laboratories.  For this study’s 
purposes, “most recent evidence of care” was defined as the most recent CD4+ T-lymphocyte, 
viral load result, or CD4:CD8 ratio laboratory result housed in HEDSS. It is considered a real-
time source of laboratory results given automatic electronic imports of these data from linked 
hospital and/or healthcare systems within the local jurisdictional area. The primary contribution 
of this system was HIV diagnostic and laboratory measures of care. 
CPCDMS. Known as the Centralized Patient Care Data Management System, CPCDMS 
is overseen by the Ryan White (RW) Grant Administration to store RW-funded client 
information and track medical appointments among their consumers, including RW eligibility 
documentation and care attendance at RW-funded providers.  From this system, “most recent 
evidence of care” was defined as the most recently attended HIV medical care appointment, the 
primary contribution of this system. 
Epic. This software houses and manages electronic health records and is the system used 
by the Harris Health System.  It is employed as a care database and produces records of 
consumer visits within the Harris Health System provider network, collectively serving the 
Harris County area which includes most of the geographic spread of Houston.  Epic captures all 
patient office visits, irrespective of HIV status or history, so “most recent evidence of care” was 
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defined as only the most recently attended medical appointment described as a primary care visit 
for HIV, the primary contribution of this system. 
STD*MIS.  A free database application, or Medical Information System, supported by 
the Centers for Disease Control and Prevention (CDC).  The Texas DSHS maintains the system 
for local and state usage for STD surveillance and public health investigation throughout Texas.  
Data is collected by the HHD to track public health follow-up activities and outcomes of partner 
elicitation and notification.  This data system contains relevant contact information, 
identification of aliases and/or other names, patient histories, STD morbidity reports, and some 
details regarding past HIV care and HIV/STD diagnostic and laboratory results.  Since a 
substantial amount of the care information is self-reported and the laboratory results are not 
comprehensive, for the purposes of this study, it was primarily used to collect contact 
information and client identifiers.  
Accurint. This comprehensive database of over 37 billion public records provides the 
most recent contact and locating information to verify a person resides within the service 
jurisdiction limits while increasing the likelihood that an SLW will be able to find the person if 
the individual qualifies for relinkage services.    The primary contribution of this system of client 
contact information.  Furthermore, it supplies mortality records, potential incarceration status, 
and additional aliases. 
JIMS. The Justice Information Management System is the Harris County Sheriff’s 
Office’s public information inquiry.  It provides the most recently updated incarceration status 
for inmates of Harris County Jail for usage by the general public.  Information is updated during 
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working days only, so information is over 24 hours old.  The primary contribution of this system 
was current incarceration status. 
TDCJ. The Texas Department of Criminal Justice online offender search is the State of 
Texas’ public information inquiry.  It provides the most recently updated incarceration status for 
inmates of the TDCJ facilities for usage by the general public.  Information is updated during 
working days only, so information is at least 24 hours old.  The primary contribution of this 
system was current incarceration status. 
All data systems contributed information regarding client contact/locating information, 
demographics, vital statistics, incarceration status, and eligibility except for JIMS and TDCJ 
which could only contribute incarceration-related details.   Collected information from each data 
system was stored in an encrypted and password protected database using Microsoft Access 
2010 software.  After record searches were completed, the final outcome of each person was 
entered into STD*MIS.  Referrals that qualified for the intervention were securely assigned to 
the SLW program through STD*MIS with the most recent contact and locating information 
available attached to the transmission.  Per referral, all data systems were record searched and 
assigned a final outcome within a single business day so the data utilized by the SLWs was the 
most recent and complete. 
Data Analysis 
The patient population was the 1287 initial potentially out-of-care persons.  Data was 
collected from the data systems described in section I. All analyses were performed using SAS 
9.4 software.  Data was stored in a secure and encrypted Microsoft Access database. 
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Demographic characteristics were age, birth sex, race, ethnicity, referral source, age, time 
since HIV diagnosis, most recent CD4+ T-lymphocyte count, most recent viral load result, client 
phone calls, client field visits, provider phone calls, and provider field visits.  Laboratory 
measures were reviewed for potential meaningful categorical breakdowns.  CD4+ T-lymphocyte 
count and viral load laboratory results are extraordinarily useful clinical and public health 
measures when categorized.  HIV infection, according to the CDC, is classified in 3 stages, with 
the 3rd Stage (AIDS) indicating when a person’s immune system has become severely 
compromised as marked by a low CD4+ T-lymphocyte count (<200 cells/µL) or opportunistic 
infection.35,36  Therefore, CD4+ T-lymphocyte count was recategorized as <200 cells/µL, >200 
cells/µL, and none reported (Table 11).  Viral load laboratory results are important measures of 
HIV medication adherence, quality of health, and risk of transmission to others, with the ideal 
goal of viral suppression, as defined by the CDC as having a plasma HIV RNA of either <200 
copies/mL or 400 copies/mL.37  The CDC’s endorsement of the international Prevention Access 
Campaign, Undetectable=Untransmissable, or U=U, emphasizes an undetectable viral load 
blocks HIV transmission, and it is based on the value of <200 copies/mL, so this threshold was 
selected.38  Therefore, viral load laboratory results were categorized as <200 copies/mL, > 200 
copies/mL, and none reported (Table 11).   
Age was presented as continuous and categorical for participant characteristic tables but 
only considered in its categorical format for statistical analyses per literature standards of known 
studies of similar outcomes.32,39 The following categories for this study were chosen to reflect 
the HIV EMA Care Continuum except for the youngest category which, for this study, had a 
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cutoff of 18 given exclusion criteria.  These groupings reflect community measures which might 
prove useful for interpretation and practical application.25   
For univariable analyses, simple logistic regression or chi-square analyses assessed initial 
relationships between independent variables and dependent variables with significance set at P-
value <.25, as levels lower than this threshold might not detect variables of potential 
importance.40–42   For independent categorical variables, contingency tables were also used to 
identify possible areas of sparse data which might cause numerical instability in the multiple 
logistic regression model.  Categories with cell sizes fewer than 5 were absorbed in the next 
related category if possible and logical to the sequence of data or assessed using Fisher’s exact 
test.  Significant variables in the univariable analyses were selected for inclusion in the primary 
multiple logistic regression model. 
Multiple logistic regression assessed significant differences between binary outcome 
measures.  The Hosmer-Lemeshow test was used to assess goodness of fit, adequate for non-
replicated data, with P-value >0.05 indicating no evidence of lack of fit.43 If all independent 
variables were significant in the initial multiple logistic regression model and the Hosmer-
Lemeshow test signaled no concern for lack of fit, then this model was considered the final 
model, unless multicollinearity diagnostics required adjustments.  If any independent variables 
were not significant in the primary multiple logistic regression model, backwards elimination 
removed variables from the primary equation using the automatic variable selection tool in SAS 
9.4 software, code “selection=backward fast slstay=0.2”.44,45 To describe this process in detail, 
the variable with the smallest significance, or largest P-value, was eliminated and the model was 
refitted with all statistics recalculated.  The procedure was restarted, eliminating another 
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variable, until the only remaining factors were those with a P-value >0.20.  Given the 
exploratory nature of this study and small number of starting independent variables, with little 
known about the potential associations of these factors and no specific exposure->outcome 
relationship of interest except for specific aim 3, the cutoff for inclusion in the final model was 
set at a moderate significance of 0.20.  The linear relationship between continuous independent 
variables and the logit was evaluated using loess plots; no transformations needed to be 
considered. 
To test for multicollinearity, the variance inflation factor (VIF) and tolerance were 
examined as diagnostics measures, with VIF>2.5 and tolerance<0.1 investigated further.  The 
condition index and regression coefficient variance-decomposition matrix were subsequently 
assessed for additional information about these relationships.  For the condition index, a 
representation of the collinearity between combinations of variables, the threshold was set at 
15.46  If a condition index exceeded this threshold and was responsible for a large proportion of 
variance (>0.90) in two or more coefficients, collinearity was considered present.46 Spearman 
correlations, for ordinal variables, and Pearson correlations, for continuous variables, provided 
additional insights into the specific relationships between independent variables, in addition to 
other underlying considerations of importance such as known literature. Problematic bivariate 
correlations resulted in deletion of one of the two variables. Collinearity and correlation 
diagnostics are discussed in the results section when potentially problematic associations were 
identified and required resolution. 
If missing data were less than 5%, then they were assumed to be missing at random and 
list-wise deletion eliminated these observations from final analysis.   
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Primary outcomes of interest per specific aim are further described below by specific 
aim. 
B.1. Aim 1 
 
The patient population was the 1287 initial referrals with outcomes and covariates 
originating from data collection via surveillance investigation databases. 
B.1.a. Statistical Analysis 
 
For univariable analyses, simple logistic regression or chi-square analyses assessed initial 
relationships between independent variables and the dependent variable with significance set at 
P-value <.25.   Categories with cell size counts fewer than 5 were absorbed in the next related 
category if possible and logical to the sequence of data or assessed using Fisher’s exact test. 
Associations between significant relations were further examined together in multiple logistic 
regression.   
Multiple logistic regression assessed significant differences between participants who 
qualified for follow up and participants who did not qualify.  The primary outcome was binary: 
No, the client did not qualify for follow up, or Yes, the client qualified follow up (N=1287).  The 
secondary analyses focused on the sub-group of referrals who qualified for follow up and those 
who did not due to recent evidence of care.  The secondary outcome was binary: No, the client 
did not qualify for the follow up due to recent evidence of care within the previous 183 days, or 
Yes, the client qualified follow up (n=1019).  Covariates of interest were birth sex, race, 
ethnicity, the most recent CD4+ T-lymphocyte count test result, the most recent viral load test 
result, age, referral source, and the time since HIV diagnosis.   
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B.2. Aim 2 
 
The patient population was the 381 referrals assigned to SLW relinkage services after 
qualifying for follow up post-surveillance investigation.  Data were collected via paper charts 
that was manually entered into the STD*MIS data system by the SLW assigned to the individual 
referral.  Possible outcomes were that a client was relinked to care versus not linked due to other 
outcomes such as the client reported already being in care, refused SLW assistance, unable to 
locate, etc. (n=381).  Secondary analyses assessed whether persons who qualified for the SL 
Program were located by an SLW.  The outcome was binary: No, the client was not located by 
an SLW, or Yes, the client was located by an SLW (n=381). 
B.2.a. Statistical Analysis 
 
For univariable analyses, simple logistic regression or chi-square analyses assessed initial 
relationships between independent variables and the dependent variable with significance set at 
P-value <.25.   Categories with cell size counts fewer than 5 were absorbed in the next related 
category if possible and logical to the sequence of data or assessed using Fisher’s exact test. 
Associations between significant relations were further examined together in multiple logistic 
regression.   
Primary multiple logistic regression analysis assessed the likelihood of being relinked to 
care for referrals who qualified for the intervention.  The primary outcome was binary: Yes (the 
patient was relinked to care) or No (the patient was not relinked to care).  Secondary multiple 
logistic assess the odds of being located by SLW outreach.  The primary outcome was binary: 
Yes (the patient was located) or No (the patient was not located).  Being successfully located was 
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defined as at least one incident of verbal and/or physical contact via phone and/or field visit by 
an SLW with the persons of interest.  Identity was confirmed by the SLW via date of birth and 
legal name. Other documentation might also be used.    
Persons lost to care can be difficult to find due to substantial lengths of time missing from 
the medical system and/or sparse locating information, despite extensive surveillance 
investigation prior to referral. Determining if the time and resources spent by the SLWs in their 
attempts to contact these persons is fruitful and/or whether other characteristics might yield 
higher response could assess best practices moving forward. 
Due to the small proportion of those successfully relinked to care, as stated previously, 
variables were recategorized where possible.  If recategorization failed to correct for expected 
cell counts fewer than 5 and/or resulted in unmeaningful categories if reduced further, Fisher’s 
exact test was substituted for chi-square analysis during univariable analyses.  However, 
continuous variables were assessed using Firth’s penalized likelihood method, proposed by King 
and Zeng in 2001, to reduce the bias of the small sample size.47  According to Greenland and 
Mansournia in their evaluation of Firth’s method versus traditional maximum likelihood 
estimation (MLE) in logistic regression analyses, MLE fails to minimize expected error or loss.48  
With small sample sizes, weak penalties subsequently yield questionable estimates, but Firth’s 
penalty (see Appendix C) offers an alternative approach.48–50  Consequently, the final logistic 
regression model also applied the Firth method due to the small sample size.47   
The backwards selection tool cannot be employed in SAS 9.4 in combination with the 
Firth method, therefore backwards selection was performed manually using the same selection 
criteria of a P-value>0.20.  The procedures were the same as described previously, with the 
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variable with the smallest significance, or largest P-value, eliminated first and the model refitted 
with all statistics recalculated.  The procedure was restarted, eliminating another variable, until 
the only remaining factors were those with a P-value >0.20. For additional guidance, the 
adjusted R-squared and Akaike information criterion (AIC) were reviewed upon deletion and 
restructuring of the model as relative measures of fit, with higher R-squared values and lower 
AIC values generally indicating better model selection. 
The yield of the SL program was assessed in terms of cumulative resources spent (i.e., 
number of contacts and number of field visits to the provider and patient, respectively) 
attempting to relink clients to care and stratified via outcomes and/or categories of interest, 
depending on exploratory analyses. 
B.3. Aim 3 
 
The patient population was the 200 intervention subgroup members and 200 non-
intervention subgroup members (see Study Design under METHODS).  For intervention subjects 
who qualified and were referred to the SL Program, data was collected via paper charts that was 
manually entered into the STD*MIS data system by the SLW assigned to the individual case.  
Possible outcomes included a client was successfully relinked to care versus other outcomes such 
as a client reported already being in care, refused SLW assistance, unable to locate, etc.  Subject 
information was collected via data systems for non-SLW outcomes (i.e., surveillance 
investigation prior to SLW referral).  For non-intervention subgroup members, the information 
was collected solely via data systems. 
B.3.a. Statistical Analysis 
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A comparison of the subjects randomized into the intervention group (n=200) and non-
intervention group (n=200) from the same referral mechanism (i.e., surveillance list generated 
from eHARS data source, see Data Analysis under METHODS) was performed to assess if 
differences existed between the samples which could impact the results.  For continuous 
variables, a two-sample t-test was performed to determine if mean differences existed in the non-
intervention group versus the intervention group among normally-distributed variables.  Non-
normal variables were analyzed using the Wilcoxon rank-sum test and, where possible, also in its 
categorical format.  A difference of proportions between these variable types were assessed using 
the chi-square test.   
For univariable analyses, simple logistic regression or chi-square analyses assessed initial 
relationships between independent variables and dependent variables with significance set at P-
value <.25.   Due to the small proportion of those successfully relinked to care, variables were 
recategorized where possible.  If recategorization failed to correct for expected cell counts fewer 
than 5 and/or resulted in unmeaningful categories if reduced further, Fisher’s exact test was 
substituted for chi-square analysis during univariable analyses.  Continuous variables were 
assessed using Firth’s penalized likelihood method.  Associations between significant relations 
were further examined together in multiple logistic regression.   
Multiple logistic regression analyses compared intervention subjects and non-intervention 
subjects to determine the odds of returning to care.  Covariates of interest are birth sex, race, 
ethnicity, age, referral source, and the time since HIV diagnosis.  The final logistic regression 
model applied the Firth method due to the small sample size, with steps described in B.2.a 
Statistical Analysis.47   
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Human Subjects, Animal Subjects, or Safety Considerations  
The parent study, under which all data was collected, was titled “Determining the most 
efficient and effective ways of identifying and returning HIV-infected persons to care: 
Evaluation of the Expanded Linkage to Care Initiative (ELCI),”and received approval to begin 
research from the Committee for the Protection of Human Subjects of the University of Texas 
Health Science Center at Houston on 25 September 2013.  This study was processed for closure 
by the Committee on 1 December 2015.  The proposed analyses herein were submitted for 
review to the Committee for Protection of Human Subjects of the University of Texas Health 
Science Center at Houston and was determined to qualify for exempt status. 
The HHD conducts regular public health activities under Chapter 81 of the Health and 
Safety Code.  Data are stored under a local area network system with restricted access to the 
network, including but not limited to authorized usernames and firewall-protection.  The 
databases for storing the collected and analyzed data are password-protected and encrypted 
within these networks, managed and tracked by the HHD’s information technology division, and 
accessible only through a pre-determined approval process which includes mandatory client 
safety and confidentially training. 
 
RESULTS 
 
A cohort (N=1287) of potentially out-of-care PLWH in the Houston/Harris County area 
were referred from 20 June 2013 through 14 July 2015.  Most referrals were male (73.3%), black 
(60.0%), and non-Hispanic (77.2%), with a mean age of 42 years. 
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Table 10. Participant characteristics overall and by initial surveillance investigation 
outcome 
Demographic 
Characteristics 
Total 
 
N=1287 
Qualified for Follow 
Up1 
n=467 
Other Outcome2 
 
n=820 
 n  % n  % n  % 
       
Age*       
     18 to 24 91 7.1 39 8.4 52 6.3 
     25 to 34 311 24.2 131 28.1 180 22.0 
     35 to 44 347 27.0 131 28.1 216 26.3 
     45 to 54 336 26.1 107 22.9 229 27.9 
     55 or older 202 15.7 59 12.6 143 17.1 
Sex       
     Male 943 73.3 349 74.7 594 72.4 
     Female 344 26.7 118 25.3 226 27.6 
Race       
     Black 771 60.0 281 60.2 490 59.8 
     White 499 39.0 177 40.0 322 39.3 
     Other 17 1.3 9 1.9 8 1.0 
Ethnicity       
     Non-Hispanic 994 77.2 353 75.6 641 78.2 
     Hispanic 293 22.8 114 24.4 179 21.8 
Referral Source       
     Provider 806 62.6 236 50.5 570 69.5 
     DIS/OOJ 81 6.3 52 11.1 29 3.5 
     Surveillance 400 31.2 179 38.3 221 27.0 
       
 Mean [SD] Mean [SD] Mean [SD] 
       
Age (years) 41.7 +11.9 40.1 +11.8 42.7 +11.9 
Time since HIV 
diagnosis (years) 
10.0 +6.8 8.9 +6.3 10.6 +7.0 
Most recent CD4 count 
(cells/µL) 
444.8 +360.8 462.4 +397.6 434.9 +338.4 
Most recent Viral Load 
(copies/mL) 
75713.0 +489112.0 45540.6 +150437.6 92624.9 +600019.0 
       
1. Referrals were assigned for follow up because they lacked any evidence of recent care and/or other outcome (e.g., incarcerate d, out of 
jurisdiction, etc.) within the previous six months so were presumed to be currently out-of-care. For intervention subjects, follow up includes 
referral to the SL Program for further case investigation.  For non-intervention subjects, follow up includes an additional surveillance 
investigation 90 days after the initial record search date. 
2.  Referrals were not assigned to follow-up due to an initial surveillance investigation outcome of recent evidence of care, incarceration, death, 
migration (OOJ), or ineligibility. 
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Of the total participants with a surveillance investigation outcome disqualifying them 
from additional follow up, 15 (1.8%) were incarcerated, 104 (12.7%) deceased, 552 (67.3%) had 
evidence of care, 131 (16.0%) were out of jurisdiction, and 18 (2.2%) were classified as ‘other.’  
The ‘other’ category included pregnancy, being under 18 years of age, having no evidence of an 
HIV diagnosis, and no locating information was received upon referral nor found during 
surveillance investigation.  For more information about exclusion criteria, please see Data 
Collection. 
CD4+ T-lymphocyte count and viral load laboratory results were only considered for 
subsequent analyses in their categorical formats due to the health importance of their clinical 
categories.   
Table 11. Subgroups – breakdown of participant characteristics into clinical categories 
for select independent variables 
Demographic 
Characteristics 
Total 
 
N=1287 
Qualified for Follow 
Up1 
n=467 
Other Outcome2 
 
n=820 
 n  % n  % n  % 
       
Most recent CD4 count       
     >200 cells/µL 919 71.4 348 74.5 571 69.6 
     <200 cells/µL 320 24.9 96 20.6 224 27.3 
    None reported 48 3.7 23 4.9 25 3.1 
Most recent Viral Load       
     >200 copies/mL 599 46.5 231 49.5 368 44.9 
     <200 copies/mL 626 48.6 209 44.8 417 50.9 
     None reported 62 4.8 27 5.8 35 4.3 
       
1. Referrals were assigned for follow up because they lacked any evidence of recent care and/or other outcome (e.g., incarcerate d, out of 
jurisdiction, etc.) within the previous six months so were presumed to be currently out-of-care. For intervention subjects, follow up includes 
referral to the SL Program for further case investigation.  For non-intervention subjects, follow up includes an additional surveillance 
investigation 90 days after the initial record search date. 
2.  Referrals were not assigned to follow-up due to an initial surveillance investigation outcome of recent evidence of care, incarceration, death, 
migration (OOJ), or ineligibility. 
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Results for Aim 1 
Table 12.  Significant factors associated with qualifying for follow up (N=1287) based on 
univariable analyses 
 
Characteristic χ2 β (SE) P-value 
    
Agec (years) 13.8475 N/A 0.0078 
Time since HIV diagnosis (years) N/A -0.0382 (0.0090) <.0001 
Referral Source 56.7996 N/A <.0001 
Most recent CD4 counta  9.2716 N/A 0.0097 
Most recent Viral Loadb   5.0355 N/A 0.0806 
    
a Most recent CD4 count is the most recent CD4+ T-lymphocyte count in cells/µL categorized as >200 cells/µL, <200 cells/µL, or no evidence 
found of ever having had a CD4+ T-lymphocyte count reported. 
b Most recent Viral Load is the most recent viral load laboratory result in copies/mL categorized as >200 copies/mL, <200 copies/mL, or no 
evidence found of ever having had a viral load reported.  
c
Age was analyzed in its categorical format only, 18-24, 25-34, 35-44, 45-54, 55+ 
 
Collinearity diagnostics produced values of VIF<2.5 and tolerance values greater than 
0.1.  Furthermore, the largest condition index value was 7.61806 with the highest, non-intercept 
proportion of variance equaling 0.60590 for age followed by time since HIV diagnosis at 
0.59932 before dropping substantially to 0.05564 for referral source.  Indications were not strong 
for collinearity, but given these results, the relationship between age and time since HIV 
diagnosis was examined further among correlation matrices, which supported a significant 
relationship between age and time since HIV diagnosis (P-value <.0001).   
Since HIV infection is a lifelong diagnosis, a correlation between age and time since HIV 
diagnosis is logical, and these variables might be useful proxy measures for each other given one 
ages with the disease.  However, a person could be older and newly diagnosed with HIV, ergo 
not everyone of older age is necessarily a long-term survivor.  Given an interaction term would 
contribute no useful clinical interpretation and one method of dealing with correlated 
independent variables is deletion of one of the two variables,51 only time since HIV diagnosis 
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was retained in the multiple logistic regression models where both were significant since it is a 
useful measure of longevity with the infection.  However, age was still considered during 
univariable relationship assessments and reflected in the narrative where significant for model 
transparency as it might be considered for future analyses or of interest to researchers conducting 
similar studies. 
  Other significant variables identified in the simple analyses and retained in the multiple 
logistic regression model were referral source, most recent CD4+ T-lymphocyte count, and most 
recent viral load laboratory result.  All other independent variables were insignificant (P-
value>.25). 
Table 13.  Regression analyses of factors associated with qualifying for follow up 
(N=1287) 
 
Characteristic 
Multiple Logistic Regression 
Odds Ratio 95%  CI P-value 
    
Time since HIV diagnosis (years) 0.968 0.950,0.986 0.0007 
Referral Source    
     Provider referent referent referent 
     DIS/OOJ 4.057 2.270,7.250 <.0001 
     Surveillance 2.054 1.590,2.653 <.0001 
Most recent CD4 count     
     >200 cells/µL referent referent referent 
     <200 cells/µL 0.752 0.555,1.020 0.0667 
     None reported 0.875 0.321,2.386 0.7944 
Most recent Viral Load      
     <200 copies/mL  referent referent referent 
     >200 copies/mL 1.368 1.058,1.769 0.0168 
     None reported 0.874 0.357,2.142 0.7689 
    
 
There were 15 observations deleted due to missing values for the response or explanatory 
variables. Post-investigation revealed these missing observations were from the explanatory 
variable time since HIV diagnosis. 
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Results from multiple logistic regression indicate that time since HIV diagnosis (β=-
0.6505, SE=0.1370, P-value=0.0007), referral source (DIS/OOJ: β=1.4004, SE=0.2962, P-
value=<0.0001; Surveillance: β=0.7197, SE=0.1307, P-value=<0.0001), and having an 
unsuppressed (>200 copies/mL) viral load (β=0.3133, SE=0.1311, P-value=0.0168) last reported 
were associated with qualifying for follow up.  DIS/OOJ and provider referrals had greater odds 
of qualifying for follow up compared to provider referrals, as did persons with an unsuppressed 
viral load as last reported at the time of surveillance investigation when compared to those with 
suppressed viral loads.  However, persons diagnosed with HIV longer had lower odds of 
qualifying for follow up.  All other results were insignificant (P-value>0.05). 
Incoming referrals were presumed to be out of care, yet each referral source presents its 
own limitations for being able to determine the accurate and current care status of their 
respective clientele.  An assessment was performed to determine if certain characteristics, 
particularly referral source, were associated with having recent evidence of care (i.e., not 
qualifying for follow up) despite being presumptively identified as having fallen out of care. 
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Table 14. Participant characteristics of referrals sent for follow up or closed because of 
evidence of care 
Demographic 
Characteristics 
Total 
 
N=1019 
Qualified for Follow 
Up1 
n=467 
Evidence of Care2 
 
n=552 
 n  % n % n % 
       
Age (years)       
     18 to 24 77 7.6 39 8.4 38 6.9 
     25 to 34 259 25.4 131 28.1 128 23.2 
     35 to 44 273 26.8 131 28.1 142 25.7 
     45 to 54 261 25.6 107 22.9 154 27.9 
     55 or older 149 14.6 59 12.6 90 16.3 
Sex       
     Male 752 73.8 349 74.7 403 73.0 
     Female 267 26.2 118 25.3 149 27.0 
Race       
     Black 601 59.0 281 60.2 320 58.0 
     White 401 39.4 177 37.9 224 40.6 
     Other 17 1.7 9 1.9 8 1.5 
Ethnicity       
     Non-Hispanic 776 76.2 353 75.6 423 76.6 
     Hispanic 243 23.9 114 24.4 129 23.4 
Referral Source       
     Provider 586 57.5 236 50.5 350 63.4 
     DIS/OOJ 71 35.5 52 11.1 19 33.2 
     Surveillance 362 7.0 179 38.3 183 3.4 
       
 Mean [SD] Mean [SD] Mean [SD] 
       
Age (years) 41.2 +11.7 40.1 +11.8 42.1 +11.7 
Time since HIV 
diagnosis (years) 
9.6 +6.7 8.9 +6.3 10.3 +6.9 
Most recent CD4 count 
(cells/µL) 
473.0 +362.8 462.4 +397.6 481.6 +332.1 
Most recent Viral Load 
(copies/mL) 
53838.7 +397145.8 45540.6 +150437.6 60525.9 +516461.1 
       
1. Referrals were assigned for follow up because they lacked any evidence of recent care and/or other outcome (e.g., incarcerate d, out of 
jurisdiction, etc.) within the previous six months so were presumed to be currently out-of-care. For intervention subjects, follow up includes 
referral to the SL Program for further case investigation.  For non-intervention subjects, follow up includes an additional surveillance 
investigation 90 days after the initial record search date. 
2. Referrals had evidence of care within the previous six months of initial surveillance investigation if there was a medical record appointment 
and/or CD4+ T-lymphocyte count and/or viral load laboratory result within this timeframe and were not sent for follow up.  
 
  Low cell counts for the category of no reported CD4+ T-lymphocyte count resulted in 
recategorization of this group to the referent.  This action might bias results towards the null.  
However, this decision also reflects the scenario where it might be assumed if this person lacks 
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evidence of laboratory tests, a proxy for steady care and monitoring adherence to ART treatment, 
then, as best represented by accessible records, they might be at risk of lower CD4+ T-
lymphocyte counts.   
Table 15. Subgroups – breakdown of participant characteristics into clinical categories 
for select independent variables 
Demographic 
Characteristics 
Total 
 
N=1019 
Qualified for Follow 
Up1 
n=467 
Evidence of Care2 
 
n=552 
 n  % n  % n  % 
       
Most recent CD4 counta       
     >200 cells/µL 812 79.7 371 79.4 441 79.9 
     <200 cells/µL 207 20.3 96 20.6 111 20.1 
Most recent Viral Loadb       
     >200 copies/mL 451 44.3 231 49.5 220 39.9 
     <200 copies/mL 535 52.5 209 44.8 326 59.1 
     None reported 33 3.2 27 5.9 6 1.1 
       
1. Referrals were assigned for follow up because they lacked any evidence of recent care and/or other outcome (e.g., incarcerate d, out of 
jurisdiction, etc.) within the previous six months so were presumed to be currently out-of-care. For intervention subjects, follow up includes 
referral to the SL Program for further case investigation.  For non-intervention subjects, follow up includes an additional surveillance 
investigation 90 days after the initial record search date. 
2. Referrals had evidence of care within the previous six months of initial surveillance investigation if there was a medical record appointment 
and/or CD4+ T-lymphocyte count and/or viral load laboratory result within this timeframe and were not sent for follow up.  
a 
Most recent CD4 Count is CD4+ T-lymphocyte count in cells/µL dichotomized as >200 cells/µL or <200 cells/µL; no evidence found of ever 
having had a CD4+ T-lymphocyte count reported was recategorized to the referent group of >200 cells/µL due to cell counts less than 5. 
 
Table 16.  Significant factors associated with having recent evidence of care as the reason 
for not qualifying for referral to the SL Program (N=1019) based on univariable analyses 
Characteristic χ2 β (SE) P-value 
    
Time since HIV diagnosis (years) N/A 0.0318 (0.00964) 0.0010 
Referral Source 30.6829 N/A <.0001 
Most recent Viral Loada   32.3537 N/A <.0001 
    
a 
Most recent Viral Load is the most recent viral load laboratory result categorized as > 200 copies/mL or <200 copies/mL or no evidence of ever 
having had a viral load laboratory result. 
 
  Age was significant in univariable analyses (continuous: β=0.0142, SE=0.00541, P-
value=0.0088; categorical: χ2=8.3722, P-value=0.0789) but dropped in the multiple logistic 
regression model due to the significance and retention of time since HIV diagnosis (see 
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correlation diagnostics post Table 12).  Other significant variables identified in the simple 
analyses included referral source and most recent viral load laboratory result; these variables 
were retained in the multiple logistic regression model. All other factors were insignificant (P-
value>0.25).   
Table 17.  Factors associated with having recent evidence of care as the reason for not 
qualifying for referral to the SL Program (N=1019) based on multiple logistic regression 
 
Characteristic 
Multiple Logistic Regression 
Odds Ratio 95%  CI P-value 
    
Time since HIV diagnosis (years) 1.029 1.009,1.049 0.0048 
Referral Source    
     Provider referent Referent referent 
     DIS/OOJ 0.376 0.203,0.696 0.0019 
     Surveillance 0.624 0.476,0.819 0.0007 
Most recent Viral Loadb      
     <200 copies/mL  referent Referent referent 
     >200 copies/mL 0.640 0.494,0.831 0.0008 
     No report 0.158 0.044,0.572 0.0049 
    
 
There were 10 observations deleted due to missing values for the response or explanatory 
variables.  Post-investigation revealed these missing observations were from the explanatory 
variable time since HIV diagnosis. 
Results suggest surveillance referral source (DIS/OOJ: β=-0.9787, SE=0.3145, P-
value=0.0019; Surveillance: β=-0.4715, SE=0.1385, P-value=0.0007), having an unsuppressed 
viral load at last report (β=-0.4456, SE=0.1328, P-value=0.0008) or no viral load reported (β=-
1.8455, SE=0.6562, P-value=0.0049), and time since HIV diagnosis (β=0.3709, SE=0.1440, P-
value=0.0100) are significantly associated with having recent evidence of care (i.e., not being 
currently out of care and needing follow-up services).  Persons originating from the DIS or OOJ 
list had 0.4 odds of having recent evidence of care and persons originating from the surveillance 
list 0.6 odds of having recent evidence of care compared to persons referred to the program by 
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providers. Furthermore, persons with unsuppressed viral loads or no reported viral loads had less 
odds of recent evidence of care and were more likely to be confirmed as presumably out of care 
and sent for follow up.  Persons longer diagnosed with HIV infection had greater odds of having 
recent evidence of care.   
Since verification of a referrals’ current care status is difficult and time consuming, more 
information is needed about the specific value of each laboratory and/or care data systems for 
producing this vital information, especially since the most diverse and comprehensive access to 
these records is housed by Health Departments.  HEDSS/Maven and eHARS contributed CD4+ 
T-lymphocyte count and viral load laboratory results while CPCDMS and Epic provided HIV-
care appointment dates. Evidence of care within the previous six months was found for 465 
(84.2%) referrals in eHARS, 83 (15.0%) referrals in HEDSS/Maven, 100 (18.1%) referrals in 
Epic, and 172 (31.1%) referrals in CPCDMS.  The average number of days between the most 
recent date for evidence of care and date of surveillance investigation was 142.4 (+134.8) for 
eHARS, 70.3 (+51.5) for Maven, 59.7 (+46.2) for Epic, and 76.8 (+55.6) for CPCDMS. 
Evidence of care could be found in multiple data systems within the same timeframe, 
with either matching or varied dates.  For instance, a person could attend a medical appointment 
twice in the same timeframe as captured by Epic and CPCDMS and/or had laboratory tests 
ordered for either of those appointments as reported to eHARS.  Evidence of care was found 
exclusively in a single data system for 348 (63.0%) referrals, among two data systems for 150 
(27.2%) referrals, among three data systems for 44 (8.0%) referrals, and among four data 
systems for 10 (1.8%) of referrals.  For eHARS, evidence of care was found exclusively in this 
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database for 283 referrals, exclusively in Maven for 9, exclusively in Epic for 16, and 
exclusively in CPCDMS for 40. 
Results for Aim 2 
 A total of 467 subjects qualified for follow up after initial surveillance investigation 
given their lack of recent evidence of care.  They could have originated from any of the original 
data sources for potentially out-of-care persons, e.g., surveillance, provider, and DIS/OOJ (see 
Study Subjects).  However, a portion of the surveillance subjects were randomized as a non-
intervention subgroup; therefore, while they could qualify for 90-day follow up, they could not 
be referred to the SL Program.  Consequently, of the 467 referrals qualifying for follow up, only 
381 (81.6%) were sent to the SL Program for SLW assistance with returning to care.  Subsequent 
analyses focus on assessing the yield of the SL Program.   
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Table 18. Participant characteristics of SL Program referrals and by SLW outcome 
Demographic 
Characteristics 
Total 
 
N=381 
Relinked to Care1 
 
n=31 
Other Outcome2 
 
n=350 
 n  % n  % n  % 
       
Age (years)       
     18-34 147 38.6 12 38.7 135 38.6 
     35-44 100 26.3 8 25.8 92 26.3 
     45 or older 134 35.2 11 35.5 123 35.1 
Sex       
     Male 282 74.0 25 80.7 257 73.4 
     Female 99 26.0 6 19.4 93 26.6 
Race       
     Black/Other 248 65.1 25 80.7 223 63.7 
     White 133 34.9 6 19.4 127 36.3 
Ethnicity       
     Non-Hispanic 292 76.6 25 80.7 267 76.3 
     Hispanic 89 23.4 6 19.4 83 23.7 
Referral Source       
     Provider 236 61.9 10 32.3 226 64.6 
     DIS/OOJ 52 13.7 13 41.9 39 11.1 
     Surveillance 93 24.4 8 25.8 85 24.3 
Client Phone Calls       
     Two or fewer 94 24.7 5 16.1 89 25.4 
     Three to six 150 39.4 8 25.8 142 40.6 
     Seven or more 137 36.0 18 58.1 119 34.0 
Client Field Visits       
     Zero 102 26.8 5 16.1 97 27.7 
     One 86 22.6 8 25.8 78 22.3 
     Two 108 28.4 9 29.0 99 28.3 
     Three or more 85 22.3 9 29.0 76 21.7 
Provider Phone Calls       
     Zero 342 89.8 5 16.1 337 96.3 
     One 15 3.94 10 32.3 5 1.4 
     Two or more 24 6.30 16 51.6 8 2.3 
Provider Field Visits       
     Zero 344 90.3 -- -- -- -- 
     One or more 37 9.7 -- -- -- -- 
       
 Mean [SD] Mean [SD] Mean [SD] 
       
Age (years) 39.6 +11.9 39.3 +13.1 39.6 +11.8 
Time since HIV diagnosis 
(years) 
8.7 +6.4 8.2 +4.7 8.8 +6.5 
Most recent CD4 count 
(cells/µL) 
453.0 +414.8 410.8 +322.5 456.1 +421.1 
Most recent Viral Load 
(copies/mL) 
46980.1 +156607.5 134940.8 +348622.6 40028.8 +128626.3 
       
1. SLW clients were relinked to care if they attended a medical appointment.  
2.  Other outcomes include incarcerated, deceased, (self-reported) already in care, out of jurisdiction, refused (SL Program services), and other. 
--. Cells suppressed due to cell counts less than 5 and no meaningful recategorizations possible.  
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Client sent to the SL Program were, on average, aged 40 years old, had been diagnosed 
with HIV for about 9 years, and were majority male, black/other race, and non-Hispanic.  The 
original category of ‘other race’ was recategorized to ‘black’ due to too few counts, and this 
classification was chosen to represent persons of color.  
 
Table 19. Subgroups – breakdown of participant characteristics into clinical categories 
for select independent variables 
 
Demographic 
Characteristics 
Total 
 
N=381 
Relinked to Care1 
 
n=31 
Other Outcome2 
 
n=350 
 n  % n  % n  % 
       
Most recent CD4 count       
     >200 cells/µL 276 72.4 15 48.4 261 74.6 
     <200 cells/µL 83 21.8 10 32.3 73 20.9 
    None reported 22 5.8 6 19.4 16 4.6 
Most recent Viral Load       
     >200 copies/mL 195 51.2 15 48.4 180 51.4 
     <200 copies/mL 160 42.0 11 35.5 149 42.6 
     None reported 26 6.8 5 16.1 21 6.0 
       
1. SLW clients were relinked to care if they attended a medical appointment.  
2.  Other outcomes include incarcerated, deceased, (self-reported) already in care, out of jurisdiction, refused (SL Program services), and other. 
 
Of the 381 persons referred to the SL Program, 31 (8.1%) were relinked to care, 193 
(50.7%) were located but had another disposition, and 157 (41.2%) were unable to locate.  Of the 
193 located with an ‘other’ disposition, these dispositions were: 11 (5.7%) deceased, 9 (4.7%) 
incarcerated, 59 (30.6%) located and refused SLW services, 90 (46.6%) located and already in 
care, 18 (9.3%) out of jurisdiction, and 6 (3.1%) other (e.g. client claims stolen identity, false 
positive/HIV-negative, mental or physically incapacitated due to other health conditions).   
Locating clients who have been out of care is a laborious task. Every available phone 
number sent to the SLW was supposed to be called a minimum of two times, and, if the client 
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could not be reached via phone, a field visit should have been made at least one time to each of 
the addresses provided during surveillance investigation, and a certified letter was left at the 
residence if no one was available to speak to the SLW regarding the client of interest.  The two 
most recent addresses for the client were collected during the initial record searches if there were 
at least two addresses linked to the referral.  Occasionally, although rare, a client might not have 
any phone numbers available, and a SLW might only be able to make field visits in their 
attempts to find the client during outreach. 
For those referrals sent to an SLW, per client, the SLWs made zero phone calls 7 times, 
one phone call 50 times, two phone calls 37 times, three to four phone calls 87 times, five to six 
phone calls 63 times, seven to eight phone calls 48 times, and nine or more phone calls 89 times.   
For the same set of referrals, per client, the SLWs made zero field visits 102 times, one field visit 
86 times, two field visits 108 times, three field visits 52 times, four field visits 21 times, and five 
more field visits 12 times.   
Provider phone calls and visits could occur at multiple points of SLW outreach to the 
client.  Examples include confirming a self-reported outcome of “already in care” where, if a 
specific provider was named, an SLW would attempt to follow up with that provider to confirm 
the care status.  During patient chart construction to determine eligibility for Ryan White 
services, laboratory results are needed (e.g., to confirm diagnosis), and an SLW might need to 
contact a provider to obtain this information on behalf of a client to alleviate the client’s burden 
of having to obtain more paperwork themselves.  Furthermore, an SLW will assist the client by 
attending the first medical appointment with them during relinkage to care to ensure remaining 
paperwork is completed as easily as possible, help communicate the process between the 
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network and the client, and provide any other resources as necessary.  For those referrals sent to 
an SLW, per client, the SLWs made zero phone calls 336 times, one phone call 15 times, two to 
four phone calls 19 times, and five or more phone calls 5 times to the provider(s).  For the same 
set of referrals, per client, the SLWs made zero field visits 344 times, one field visit 9 times, two 
field visits 13 times, three field visits 6 times, and four or more field visits 9 times to the 
provider(s). 
Table 20.  Self-reported reasons for falling out of care for those successfully contacted by 
SLWs 
Self-Reported Reasons for Being Out of Care Total 
Unknown – no show at scheduled intake/medical appointments 31 
Unknown – refused to disclose to SLW 24 
Feels good/was healthy at last doctor appointment 9 
Claims to already be in care but no provider reported 7 
Unfriendly care setting 6 
Does not want/need HHD services  4 
SLW lost contact* 3 
Does not believe HIV test results  3 
Reportedly has private/other insurance, no supplemental services needed  2 
Lives out of the United States and is provided care out of the United States  2 
Only ancillary services requested 2 
Relinked to care on their own without SLW assistance 2 
Lack of support (e.g., economic, medical, social, mental, etc.) 2 
Cost of HIV Care 1 
Other life issues more important 1 
Believes they do not qualify for assistance/services  1 
Moved out of the jurisdiction and established care 1 
Other life issues more important 1 
Wait times (to schedule an appointment) 1 
Financial Difficulties 1 
Work Schedule 1 
Does not want to take medication 1 
Does not want to register every year for (Ryan White) eligibility  1 
Wants holistic medicine/alternative treatments  1 
Note1. Results are not mutually exclusive. 
*. Includes but is not limited to working/established phone number disconnected, client moved and provided no viable forwarding address, client 
stopped returning phone calls and/or responding to additional follow up attempts, etc.  
 
Of the 224 clients with some sort of successful contact and/or relinkage to care, an 
attempt was made to determine their reasons for falling out of care. Clients could report multiple 
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reasons, totaling 3 per person, therefore Table 20 does not represent mutually exclusive results.  
Most persons were out of care for unknown reasons and were subsequently lost to relinkage 
attempts when they failed to attend their intake or medical appointment.  The primary reason 
reported to SLWs for being out of care is that the client feels good and/or reported they were in 
good health at their last care appointment.  The second reason was the clients reported being 
already in care although they failed to report evidence of a current provider and/or recent 
appointment followed by a third reason of they did not believe they needed HHD services.  The 
remaining reasons for having fallen out of care are diverse and seemingly unique to the situation 
of the individual. 
Table 21.  Significant factors associated with being successfully relinked to care by an 
SLW (N=381) from univariable analyses 
Characteristic χ2 P-value 
   
Race 3.5926 0.0580 
Referral Source 24.6117 <.0001 
Most recent CD4 count 15.1729 0.0005 
Most recent Viral Load   4.6736 0.0966 
Client Phone Calls 7.1614 0.0279 
Provider Phone Calls  N/A <.0001a 
Provider Field Visits  N/A <.0001a 
   
a. Fisher’s exact test. 
 
  Two independent variables, provider phone calls, dichotomized as 0 vs 1 or more, and 
provider field visits, dichotomized as 0 vs 1 or more, were significantly associated with the 
relinkage outcome variable during univariable analyses using Fisher’s exact test (P-value<.0001) 
but were dropped from the final multivariable model due to numerical instability.  Observed 
and/or expected cell counts for some cells were at or close to 0 despite recategorizing to the 
lowest possible level, creating large variations between groups in a small sample size.  Variables 
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of significance (P-value<0.25) in simple analyses and retained in the multiple logistic regression 
model include race, referral source, most recent CD4 count, most recent viral load laboratory 
result, and client phone calls.  All other variables were insignificant (P-value>0.25). 
Table 22.  Factors associated with being successfully relinked to care by an SLW 
(N=381) from multiple logistic regression 
Characteristic 
Multiple Logistic Regression 
Odds Ratio 95%  CI P-value 
    
Race    
    White referent referent referent 
     Black/Other 1.974 0.822,5.381 0.1436 
Referral Source    
     Provider referent referent referent 
     DIS/OOJ 7.242 2.603,20.343 0.0001 
     Surveillance 2.722 1.011,7.186 0.0396 
Most recent CD4 count     
     >200 cells/µL referent referent referent 
     <200 cells/µL 2.347 0.965,5.512 0.0508 
     None reported 2.768 0.726,10.234 0.1324 
Client Phone Calls    
     Two or fewer referent referent referent 
     Three to six 1.571 0.487,5.586 0.4541 
     Seven or more 3.879 1.359,12.770 0.0143 
    
 
There were no observations deleted due to missing values for the response or explanatory 
variables. 
Most recent viral load result was eliminated from the final model upon backwards 
selection.  DIS/OOJ referral source was associated with successful relinkage to care (β=1.9799, 
SE=0.5175, P-value=0.0001) as was surveillance referral source (β=1.0015, SE=0.4865, P-
value=0.0396). A last reported CD4+ T-lymphocyte count of less than 200 cells/µL was 
borderline significant (β=0.98530, SE=0.4366, P-value=0.0508), while a total of seven or more 
phone calls to the client by the SLW (β=1.3556, SE=0.5536, P-value=0.0143) was significantly 
related to returning to care.  It is interesting to note that a high number of phone calls (>7 times) 
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per client was significantly related with relinkage to care, but the middle range of three to six 
was not.  An SLW is required to attempt each phone number available per client a minimum of 
two times until they reach the client and/or the phone number is disconnected, then they stop. 
For example, if a client has 4 numbers, an SLW would make a minimum of 8 attempts to 
reach that person if none of the outreaches are successful.  Clients called seven or more times 
had more than 3 times the odds of successful relinkage to care.  Persons from the DIS/OOJ 
referral source had an almost 8 times greater odds of being relinked to care than those from the 
provider source, while persons from the surveillance list had almost 3 times greater odds 
compared to those from the provider source.  
There was an average of 69.7 (+95.5) days from the date of receipt by the SL Program to 
the intake date with an SLW.  There was an average of 24.0 (+18.1) days from the intake with an 
SLW to the first medical appointment. 
An exploratory analysis was conducted to determine if there were any significant 
associations with being located by an SLW if persons qualified for the SL Program.  Persons lost 
to care are difficult to find due to sometimes substantial lengths of time missing from the medical 
system and/or sparse locating information, despite extensive surveillance investigation prior to 
referral. Determining if the time and resources spent by the SLWs in their attempts to contact 
these persons is fruitful and/or whether other characteristics might yield higher response could 
assess best practices moving forward. 
Being successfully located was defined as at least one incident of verbal and/or physical 
contact via phone and/or field visit by an SLW with the persons of interest.  Identity is confirmed 
by the SLW via date of birth and legal name. Other documentation might also be used. 
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  Table 23. Participant characteristics of SL Program referrals and by SLW outreach 
attempt outcome 
Demographic 
Characteristics 
Total 
N=381 
Located by SLW1 
n=224 
Unable to Locate2 
n=157 
 n  % n  % n  % 
Age (years)       
     18 to 24 37 9.7 20 8.9 17 10.8 
     25 to 34 110 28.9 63 28.1 47 29.9 
     35 to 44 100 26.3 48 21.4 52 33.1 
     45 to 54 88 23.1 58 25.9 30 19.1 
     55 or older 46 12.1 35 15.6 11 7.0 
Sex       
     Male 282 74.0 169 75.5 113 72.0 
     Female 99 26.0 55 24.6 44 28.0 
Race       
     Black/Other 248 65.1 149 66.5 99 63.1 
     White 133 34.9 75 33.5 58 36.9 
Ethnicity       
     Non-Hispanic 292 76.6 175 78.1 117 74.5 
     Hispanic 89 23.4 49 21.9 40 25.5 
Referral Source       
     Provider 236 62.0 127 56.7 109 69.4 
     DIS/OOJ 52 13.7 40 17.9 12 7.6 
     Surveillance 93 24.4 57 25.5 36 22.9 
Client Phone Calls       
     Two or fewer 94 24.7 64 28.6 30 19.1 
     Three to six 150 39.4 87 38.8 63 40.1 
     Seven or more 137 36.0 73 32.6 64 40.8 
Client Field Visits       
     Zero 102 26.8 -- -- -- -- 
     One 86 22.6 -- -- -- -- 
     Two 108 28.4 43 19.2 65 41.4 
     Three or more 85 22.3 29 13.0 56 35.7 
Provider Phone Calls       
     Zero 342 89.8 -- -- -- -- 
     One or more 39 10.2 -- -- -- -- 
Provider Field Visits       
     Zero 344 90.3 -- -- -- -- 
     One or more 37 9.7 -- -- -- -- 
 Mean [SD] Mean [SD] Mean [SD] 
Age (years) 39.6 11.9 9.3 6.7 37.9 10.8 
Time since HIV diagnosis 
(years) 
8.7 6.4 40.8 12.5 8.0 5.8 
Most recent CD4 count 
(cells/µL) 
453.0 414.8 440.9 291.8 468.8 536.0 
Most recent Viral Load 
(copies/mL) 
46980.1 156608.0 42394.3 147117.6 53104.6 168754.7 
1. Successfully located was defined as at least one incident of verbal and/or physical contact via phone and/or field visit by a n SLW with the 
persons of interest.   
2.  Unable to locate includes client could not be contacted via phone and/or field visit (e.g., no response).  
--. Cells suppressed due to cell counts less than 5 and no meaningful recategorizations possible.  
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Table 24. Subgroups – breakdown of participant characteristics into clinical categories 
for select independent variables 
 
Demographic 
Characteristics 
Total 
 
N=381 
Located by SLW1 
 
n=224 
Other Outcome2 
 
n=157 
 n  % n  % n  % 
       
Most recent CD4 counta       
     >200 cells/µL 298 78.2 175 78.1 123 78.3 
     <200 cells/µL 83 21.8 49 21.9 34 21.7 
Most recent Viral Loadb       
     >200 copies/mL 195 51.2 100 44.6 95 60.5 
     <200 copies/mL 186 48.8 124 55.4 62 39.5 
       
1. Successfully located was defined as at least one incident of verbal and/or physical contact via phone and/or field visit by a n SLW with the 
persons of interest.   
2.  Unable to located includes client could not be contacted via phone and/or field visit (e.g., no response).  
a Most recent CD4 Count is CD4+ T-lymphocyte count in cells/µL dichotomized as >200 cells/µL or <200 cells/µL. 
b Most recent Viral Load is the most recent viral load laboratory result dichotomized as > 200 copies/mL or <200 copies/m L. 
 
 
Table 25.  Significant factors associated with being located by an SLW (N=381) from 
univariable analyses 
Characteristic χ2 β (SE) P-value 
    
Referral Source 9.7099 N/A 0.0078 
Client Phone Calls 5.1048 N/A 0.0779 
Client Field Visits 96.5158 N/A <.0001 
Provider Phone Calls  N/A N/A <.0001a 
Provider Field Visits  N/A N/A <.0001a 
Most recent Viral Load Resultb 9.3003 N/A 0.0023 
Time since HIV Diagnosis  (years) N/A 0.0338 0.0474 
    
a. Fisher’s exact test. 
b Most recent Viral Load is the most recent viral load laboratory result dichotomized as > 200 copies/mL or <200 copies/mL; no evidence of ever 
having had a viral load laboratory result was recategorized to the referent group of >200 copies/mL due to small cell sizes. 
 
  Two independent variables, provider phone calls, dichotomized as 0 vs 1 or more, and 
provider field visits, dichotomized as 0 vs 1 or more, were significantly associated with the 
relinkage outcome variable during univariable analyses using Fisher’s exact test (P-value<.0001) 
but were dropped from the final multivariable model due to numerical instability.  Observed 
and/or expected cell counts for some cells were at or close to 0 despite recategorizing to the 
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lowest possible level, creating large variations between groups in a small sample size and 
numerical instability. Age was significant in univariable analyses (continuous: β=0.0216, 
SE=0.00901, P-value=0.0165; categorical: χ2=12.7742, P-value=0.0124) but dropped in the 
multivariable model due to the significance and retention of time since HIV diagnosis.   
 
Table 26.  Factors associated with being located by an SLW (N=381) based on multiple 
logistic regression. 
Characteristic 
Multiple Logistic Regression 
Odds Ratio 95%  CI P-value 
    
Time since HIV Diagnosis  (years) 1.029 0.988,1.074 0.1707 
Referral Source    
     Provider referent referent referent 
     DIS/OOJ 3.489 1.609,7.919 0.0023 
     Surveillance 1.356 0.753,2.449 0.3140 
Most recent Viral Load      
     <200 copies/mL  referent referent referent 
     >200 copies/mL 0.587 0.355,0.967 0.0386 
Client Phone Calls    
     Two or fewer referent referent referent 
     Three to six 1.634 0.808,3.381 0.1794 
     Seven or more 2.341 1.130,5.003 0.0255 
Client Field Visits    
     Zero referent referent referent 
     One 0.074 0.022,0.195 <.0001 
     Two 0.024 0.007,0.065 <.0001 
     Three or more 0.017 0.005,0.048 <.0001 
    
 
There were 10 observations deleted due to missing values for the response or explanatory 
variables.  Post-investigation revealed these missing observations were from the explanatory 
variable time since HIV diagnosis. 
DIS/OOJ referral source was significantly associated with locating the client (β=1.2497, 
SE=0.4098, P-value=0.0023), as was having a recent viral load laboratory result last reported as 
>200 copies/mL (β=-0.5320, SE=0.2572, P-value=0.0386), calling the client seven or more 
times (β=0.8506, SE=0.3809, P-value=0.0255), and making incrementally higher number of 
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field visits to the client’s addresses (one: β=-2.6091, SE=0.5399, P-value=<.0001; two: β=-
3.7123, SE=0.5417, P-value=<.0001; three or more: β=-4.0468, SE=0.5645, P-value=<.0001).  
DIS/OOJ referrals had 3.5 greater odds of being located by an SLW than provider referrals, and 
clients contacted seven or more times via phone by an SLW had 2.3 greater odds of being 
located than those contacted two or fewer times.  In comparison, persons with a last reported 
viral load that was unsuppressed or any number of field visits from an SLW had lower odds of 
being successfully reached by an SLW.   
Results for Aim 3 
A subgroup of the population was randomized as intervention (n=200) and non-
intervention subjects (n=200) from the surveillance data source (see Study Subjects).  
Intervention participants were referred to the SL Program if record searches determined they did 
not have recent evidence of care nor any other disposition. Non-intervention participants were 
assigned for surveillance investigation follow up 90 days later if the first record search 
determined they did not have recent evidence of care nor any other disposition.  Priority 
population information was only reported for these subjects given its original data source, the 
surveillance list (i.e., eHARS), contains an existing field with this information.  However, this 
field is sparsely populated (unrecorded: n=332) with preset indicators chosen by the National 
HIV/AIDS Strategy and adapted by the CDC.52,53  This information was excluded from tables 
and analyses given the lack of data, but overall information is provided here to better represent 
the population.   
Of the total randomized population (n=400), 5 (1.3%) were transgender persons, all 
identifying as male-to-female (birth sex male), 9 (2.3%) were young (i.e., 13-24 years old, as 
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preset by the data system, although all participants in this study were aged 18+) and black, 54 
(13.5%) were injection drug users (IDU), and 332 (83.0%) were unrecorded.  For the IDU group, 
among non-intervention subjects, 13 qualified for follow up and 14 did not qualify for follow up; 
among intervention subjects, 14 qualified for follow up and 13 did not qualify for follow up.  For 
the same priority population, IDU, of those who qualified for follow up among non-intervention 
subjects, 3 returned to care and 10 remained out of care; of those who qualified for follow up 
among intervention subjects, 0 were relinked to care and 14 remained out of care.  All other 
priority populations reported were too few counts.  Unrecorded was not included.      
The randomized subgroup was aged 44 years on average with 11 years as the mean time 
since HIV diagnosis and majority male, black, and non-Hispanic.  Greater than half of all 
randomized subjects had CD4+ T-lymphocyte counts >200 cells/µL and viral load results <200 
copies/mL at last report.   
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Table 27. Participant characteristics of randomized intervention and non-intervention subjects overall and by initial 
surveillance investigation outcome (N=400) 
Demographic 
Characteristics 
Total Qualified for Follow Up1 Other Outcome2 
 Intervention Group Non-Intervention 
Group 
Intervention Group Non-Intervention 
Group 
Intervention Group Non-Intervention 
Group 
N=200 N=200 n=93 n=86 n=107 n=114 
n % n % n % n % n % n % 
Age (years)             
     18 to 34 47 23.5 42 21.0 17 18.3 23 26.7 30 28.0 19 16.7 
     35 to 44 58 29.0 63 31.5 31 33.3 31 36.1 27 25.2 32 28.1 
     45 to 54 60 30.0 55 27.5 30 32.3 19 22.1 30 28.0 36 31.6 
     55 or older 35 17.5 40 20.0 15 16.1 13 15.1 20 18.7 27 23.7 
Sex             
     Male 156 78.0 151 75.5 73 78.5 67 77.9 83 77.6 84 73.7 
     Female 44 22.0 49 24.5 20 21.5 19 22.1 24 22.4 30 26.3 
Race             
     Black/Other 
Race 
113 56.5 97 48.5 58 62.4 42 48.8 55 51.4 55 48.3 
     White 87 43.5 103 51.5 35 37.6 44 51.2 52 48.6 59 51.8 
Ethnicity             
     Non-Hispanic 159 79.5 145 72.50 74 79.6 61 70.9 85 79.4 84 73.7 
     Hispanic 41 20.5 55 27.50 19 20.4 25 29.1 22 20.6 30 26.3 
 Mean [SD] Mean [SD] Mean [SD] Mean [SD] Mean [SD] Mean [SD] 
Age (years) 43.9 +11.2 44.2 +11.0 43.8 10.2 42.3 +10.9 43.9 12.0 45.6 +10.9 
Time since HIV 
diagnosis (years) 
10.5 +6.3 11.1 +6.5 9.8 6.3 9.5 +6.1 11.1 6.3 12.3 +6.5 
Most recent CD4 
count (cells/µL) 
473.9 +324.6 467.1 +277.6 448.2 257.8 502.1 +313.7 496.3 372.9 441.0 +245.6 
Most recent Viral 
Load (copies/mL) 
75918.8 +411051.6 32641.4 +113130.9 74203.1 253722.8 39528.4 +121949.9 77394.0 510235.8 27460.9 +106277.6 
1. Intervention and non-intervention subjects were assigned for follow up because they lacked any evidence of recent care and/or other outcome so were presumed to be currently out-of-care. For 
intervention subjects, follow up entailed assignment to the SL Program for SLW assistance with returning to care. For the non-intervention subjects, follow up entailed an additional surveillance 
investigation (i.e., record search) 90 days after the initial record search date. 
2. ‘Other Outcomes’ for intervention and non-intervention subjects were identical and include: incarcerated, deceased, evidence of care, out of jurisdiction, and ineligib le.  ‘Other Outcomes’ originated 
from the first surveillance investigation. 
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Table 28. Subgroups – breakdown of randomized intervention and non-intervention participant characteristics into clinical 
categories for select independent variables (N=400) 
Demographic Characteristics Total Qualified for Follow Up1 Other Outcome2 
 
 Intervention 
Subgroup 
Non-Intervention 
Subgroup 
Intervention 
Subgroup 
Non-Intervention 
Subgroup 
Intervention 
Subgroup 
Non-Intervention 
Subgroup 
N=200 N=200 n=93 n=86 n=107 n=114 
n % n % n % n % n % n % 
             
Most recent CD4 counta             
     >200 cells/µL 156 78.0 168 84.0 73 78.5 73 84.9 83 77.6 95 83.3 
     <200 cells/µL 44 22.0 32 16.0 20 21.5 13 15.1 24 22.4 19 16.7 
Most recent Viral Loadb             
     >200 copies/mL 80 40.0 74 37.0 37 39.8 35 40.7 64 59.8 39 34.2 
     <200 copies/mL 120 60.0 126 63.0 56 60.2 51 59.3 43 40.2 75 65.8 
             
1. Intervention and non-intervention subjects were assigned for follow up because they lacked any evidence of recent care and/or other outcome so were presumed to be currently out-of-care. For 
intervention subjects, follow up entailed assignment to the SL Program for SLW assistance with returning to care. For the non-intervention subjects, follow up entailed an additional surveillance 
investigation (i.e., record search) 90 days after the initial record search date.  
2. ‘Other Outcomes’ for intervention and non-intervention subjects were identical and include: incarcerated, deceased, evidence of care, out of jurisdiction, and ineligib le.  ‘Other Outcomes’ originated 
from the first surveillance investigation. 
a 
Most recent CD4 Count is CD4+ T-lymphocyte count in cells/µL dichotomized as >200 cells/µL or <200 cells/µL; no evidence found of ever having had a CD4+ T-lymphocyte count reported was 
recategorized to the referent group of >200 cells/µL due to cell counts less than 5. 
b Most recent Viral Load is the most recent viral load laboratory result dichotomized as > 200 copies/mL or <200 copies/mL; no evidence of ever having had a viral load laboratory result was 
recategorized to the referent group of >200 copies/mL due to small cell sizes. 
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Of the 200 non-intervention subjects, 114 (57.0%) received an initial record search 
disposition.  Of these, primary surveillance investigation found 2 (1.75%) persons were 
incarcerated, 1 (0.88%) was deceased, 92 (80.7%) had recent evidence of care, and 19 (16.7%) 
were out of jurisdiction.  A remaining 86 (43%) qualified for 90-day follow up without SLW 
intervention.  The second surveillance investigation after the 90-day follow up period found that 
15 (17.4%) had evidence of care, i.e., had returned to care, while 4 (4.7%) were out of 
jurisdiction and 67 (77.9%) had no evidence of care or any other outcome and were presumed to 
still be out of care within the Houston/Harris County area.  Within the 90-day follow-up period, 
the mean number of days for the non-intervention subjects to return to care was 45.9 (+31.7). 
Of the 200 intervention subjects, initial surveillance investigation produced 107 (53.5%) 
dispositions.  Of these, 2 (1.9%) were deceased, 14 (13.1%) were out of jurisdiction, and 91 
(85.1%) had recent evidence of care.  Ninety-three (46.5%) individuals qualified for follow up 
and were referred to the SL Program.  Of these, 8 (8.6%) were relinked to care; remaining 
dispositions were 1 (1.1%) deceased, 2 (2.2%) incarcerated, 34 (36.6%) already in care, 2 (2.3%) 
located out of jurisdiction, 35 (37.6%) were unable to locate, and 11 (11.8%) were located but 
refused SLW services.  The mean number of days for intervention subjects to be relinked to care 
from the intake date with an SLW was 12.0 (+11.0).   
A comparison of the subjects randomized into the intervention group (n=200) and non-
intervention group (n=200) from the same referral source (e.g., surveillance list) indicated no 
differences existed between the samples (P-value>0.05).
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Table 29. Participant characteristics of randomized intervention and non-intervention subjects assigned for follow up and by 
follow-up outcome (N=179) 
Demographic 
Characteristics 
Total Returned to Care1 Other Outcome2 
 Intervention 
Subgroup 
Non-Intervention 
Subgroup 
Intervention 
Subgroup 
Non-Intervention 
Subgroup 
Intervention 
Subgroup 
Non-Intervention 
Subgroup 
 N=93 N=86 n=8 n=15 n=85 n=71 
 n % n % n % n % n % n % 
             
Age (years)             
     <45  48 51.6 35 40.7 -- -- 9 60.0 -- -- 45 63.4 
     >45  45 48.4 51 59.3 -- -- 6 40.0 -- -- 26 36.6 
Sex             
     Male 73 78.5 67 77.9 -- -- -- -- -- -- -- -- 
     Female 20 21.5 19 22.1 -- -- -- -- -- -- -- -- 
Race             
     Black/Other 58 62.4 42 48.8 -- -- 5 33.3 -- -- 37 52.1 
     White 35 37.6 44 51.2 -- -- 10 66.7 -- -- 34 47.9 
Ethnicity             
     Non-Hispanic 74 79.6 61 70.9 -- -- 9 40.0 -- -- 52 26.8 
     Hispanic 19 20.4 25 29.1 -- -- 6 60.0 -- -- 19 73.2 
             
 Mean [SD] Mean [SD] Mean [SD] Mean [SD] Mean [SD] Mean [SD] 
             
Age (years) 43.8 10.2 42.5 +10.9 36.1 6.4 42.7 +11.7 44.5 10.2 42.5 +10.8 
Time since HIV 
diagnosis (years) 
9.8 6.3 9.5 +6.1 7.5 3.4 9.5 +4.9 10.0 6.5 9.5 +6.4 
Most recent CD4 
count (cells/µL) 
448.2 257.8 502.1 +313.7 450.8 410.1 472.9 +299.6 448.0 242.5 508.4 +318.4 
Most recent Viral 
Load (copies/mL) 
74203.1 253722.8 39528.4 +121949.9 264147.3 549703.2 51325.3 +104360.1 56113.2 203191.9 37000.5 +125929.5 
             
1. Intervention subjects returned to care if they were successfully relinked to medical care through SLW assistance.  Non-intervention subjects returned to care if record searches during the second 
surveillance investigation yielded a medical appointment and/or CD4+ T-lymphocyte count and/or viral load laboratory result during the 90-day follow up period. 
2. ‘Other Outcomes’ for intervention subjects include: incarcerated, deceased, already in care, out of jurisd iction, refused services, unable to locate, and other.  ‘Other Outcomes’ for non-intervention 
subjects include: evidence of care, incarcerated, deceased, and out of jurisdiction.   
*.  Time in years, with smallest categorize absorbed into the next closet group. 
--. Cells suppressed due to cell counts less than 5 and no meaningful recategorizations possible. 
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Table 30. Subgroups – breakdown of randomized intervention and non-intervention participant characteristics into clinical 
categories for select independent variables (N=179) 
Demographic Characteristics Total 
 
 
Returned to Care1 
 
Other Outcome2 
 
 
Intervention 
Subgroup 
Non-
Intervention 
Subgroup 
Intervention 
Subgroup 
Non-
Intervention 
Intervention 
Subgroup 
Non-
Intervention 
Subgroup 
N=93 N=86 n=8 n=15 n=85 n=71 
n % n  % n % n  % n % n  % 
             
Most recent CD4 counta             
     >200 cells/µL 69 81.2 73 84.9 -- -- -- -- -- -- -- -- 
     <200 cells/µL 16 18.8 13 15.1 -- -- -- -- -- -- -- -- 
Most recent Viral Loadb             
     >200 copies/mL 37 39.8 35 40.7 -- -- 5 33.3 -- -- 30 42.3 
     <200 copies/mL 56 60.2 51 59.3 -- -- 10 66.7 -- -- 41 57.8 
             
1. Intervention subjects returned to care if they were successfully relinked to medical care through SLW assistance.  Non-intervention subjects returned to care if record searches during the second 
surveillance investigation yielded a medical appointment and/or CD4+ T-lymphocyte count and/or viral load laboratory result during the 90-day follow up period. 
2. ‘Other Outcomes’ for intervention subjects include: incarcerated, deceased, already in care, out of jurisdiction, refused services, unable to locate, and other.  ‘Other Outcomes’ for non-intervention 
subjects include: evidence of care, incarcerated, deceased, and out of jurisdiction.   
a Most recent CD4 Count is CD4+ T-lymphocyte count in cells/µL dichotomized as >200 cells/µL or <200 cells/µL; no evidence found of ever having had a CD4+ T-lymphocyte count reported was 
recategorized to the referent group of >200 cells/µL due to cell counts less than 5. 
b Most recent Viral Load is the most recent viral load laboratory result dichotomized as > 200 copies/mL or <200 copies/mL; no evidence of ever having had a viral load laboratory result was 
recategorized to the referent group of >200 copies/mL due to small cell sizes. 
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To assess whether the SL Program impacts relinkage to care, analyses were performed to 
determine if, among those persons qualifying for follow up (n=179) for the randomized group, 
subjects were successfully relinked to care based on intervention group status.   
 
Table 31.  Significant factors associated with returning to care (N=179) from univariable 
analyses 
Characteristic χ2 β (SE) P-value 
    
Ethnicity 1.4815 N/A 0.2235 
Age (years) 1.7044 N/A 0.1917 
Intervention Status 3.1179 N/A 0.0774 
    
*.  Age is categorical; 44 years or less vs 45 years or greater 
 
  Unlike previous analyses, the variable Age was significantly associated (P-value>0.25) in 
univariable analyses and time since HIV diagnoses was not.  Given these results, Age was 
included in the final multiple logistic regression model since the correlation between Age and 
time since HIV diagnosis was negated. 
 
Table 32.  Factors associated with returning to care (N=179) based on full multiple 
logistic regression model. 
Characteristic 
Multiple Logistic Regression 
Odds Ratio 95%  CI P-value 
    
Age (years)    
     44 or fewer referent referent referent 
     45 or greater 0.636 0.238,1.575 0.3408 
Ethnicity    
     Non-Hispanic referent referent referent 
     Hispanic 1.560 0.590,3.888 0.3511 
Intervention Status    
    Non-SLW referent referent referent 
    SLW 0.504 0.197,1.218 0.1350 
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  Results in the full multiple logistic regression model are provided in Table 32 prior to 
backwards elimination.  Based on a significance level of P-value<0.05, none of the variables 
were significant predictors of the outcome prior to subsequent model fit evaluation.  Ethnicity 
was subsequently eliminated, with remaining significance values indicating further adjustment 
was still needed (P-value>0.20), so Age was omitted.  Therefore, the final model was log(p/(1-
p))=β0 + β1*Intervention Status.  Although the Hosmer-Lemeshow test failed to reject the null 
hypothesis for the full model, so there was no evidence for lack of fit, and a comparison of AIC 
and R-square values suggests the full model (Table 32) is the best fit, there was minimal 
variation between the AIC and R-square values across the full model, model with the elimination 
of Ethnicity, and model with the elimination of Age (e.g., less than a 0.012 difference for R-
square values between the highest and lowest; less than a 3.0 difference for AIC values between 
the highest and lowest).   
  Given these results and to further inform the primary relationship of interest, backwards 
elimination was still performed, leading to the eventual final model.  The Hosmer-Lemeshow 
test failed to produce a significant value as there was only one binary categorical predictor in this 
model. 
Table 33.  Factors associated with returning to care (N=179) based on reduced multiple 
logistic regression model. 
Characteristic 
Multiple Logistic Regression 
Odds Ratio 95%  CI P-value 
    
Intervention Status    
    Non-SLW referent referent referent 
    SLW 0.459 0.180,1.098 0.0890 
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  Intervention Status was insignificant (β=-0.3898, SE=0.2292, P-value=.0890).  Persons 
randomized to an SLW were about half as likely to be relinked to care compared to those who 
returned to care on their own without the intervention, although results were above the cutoff for 
significance at P-value>0.05. 
Figure 4. Description of probability of returning to care based on intervention status 
(SLW vs. non-SLW) for persons randomized and qualifying for follow up (N=179) 
 
 
  Figure 4 is a visual representation of the relationship between the main independent 
variable of interest, intervention status (e.g., assigned to an SLW vs. not assigned to an SLW 
after qualifying for follow up post-surveillance investigation), and the outcome of interest (e.g., 
76 
 
returned to HIV care vs. not returned to HIV care).  As depicted, persons not assigned to the SL 
program had a slightly higher probability of returning to HIV care compared to those assigned to 
the SL Program, although results were insignificant at an alpha of 0.05 (P-value=.0890).   
 
Discussion 
The majority of PLWH presumed to be out of care and referred to the HHD for record 
search investigation failed to qualify for follow up.  The primary reason was they had evidence 
of care (67.3%) followed by out of jurisdiction (16.0%), validating the contribution health 
departments can make in comprehensive health record knowledge while highlighting the 
majority of presumptions about the out-of-care population are likely inflated.  Despite 
differences in methodologies, D2C programs using various surveillance and care investigat ions 
to identify and locate presumed out-of-care persons have consistently learned greater than 50% 
of all presumed lost-to-care persons failed to qualify for public health follow up, having been 
found to be in recent care with other factors such as migration, death, and incarceration distorting 
engagement- in-care estimates.18,19,21,32,54 Migration might be particularly characteristic in 
Houston given its proximity to the Mexico border, as some people reported being in care but out 
of country (. 
Table 20). 
DIS/incoming OOJ referrals, surveillance referrals, and having had an unsuppressed viral 
load at last report were associated with greater odds of qualifying for follow up while persons 
diagnosed with HIV longer had lower odds of qualifying for follow up.  Although not equal 
measures, age was eliminated from the statistical models because it was strongly correlated with 
time since HIV diagnosis, and retaining time since HIV diagnosis contributed a unique measure 
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which has been often overlooked in D2C programs.  However, when one considers the 
correlation with age, the significance of persons diagnosed with HIV for a longer period having 
less odds of qualifying for follow up might reflect trends in the Houston EMA Care Continuum.  
When broken down by age groups in 2016, ranging from 13-24, 25-34, 35-44, 45-54, to 55+, 
retention in care and viral suppression increased sequentially across all groups.  Literature 
supports persons of older age being more likely to be virally suppressed with greater retention 
and treatment adherence.55–58  Someone of older age might not be newly diagnosed, but given, as 
someone both ages and lives longer with HIV, they might be more likely to face an increasing 
number of health challenges, so they also might be more likely to seek out medical care and have 
more motivation to stay in care.  This possibility is reflected in . 
Table 20, where some persons reported being out of care because they “feel good/was 
healthy at last doctor appointment,” although this relationship might be extraneous.  Future 
studies might consider measuring the effects of the length of HIV diagnosis given the lack of 
knowledge of this factor on relinkage to care. They might also consider a new variable factoring 
in both measures of time since HIV diagnosis and year of birth. 
DIS/incoming OOJ referrals had recent contact with PLWH, thereby making it more 
likely that a person would be correctly identified, initially, as out of care and in the jurisdiction, 
alive, and not incarcerated.  One D2C study acknowledged an usually high rate of relinkage to 
care at 71.2% for persons confirmed out of care, and this program employed expanded partner 
services (ExPS) in lieu of service linkage workers.59  Although their study population originated 
solely from surveillance sources and served a markedly differently population, one which was 
non-metropolitan and cross-county in upstate New York, all record-search investigations and 
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patient outreach were conducted by ExPS-designated staff members, which might speak to an 
alternative relinkage-to-care strategy worth exploring. 
Provider referrals might benefit from additional outreach by program staff and/or 
restrictive criteria for out-of-care persons.  Providers reserve a specific scope of knowledge for 
the patients they serve in that they are restricted to the electronic medical records (EMRs) under 
their purview and authority, which might explain why clinic-based data has yielded potentially 
out-of-care clients who have simply moved out of jurisdiction or to another care system.33  
Nonetheless, providers are integral to the care-prevention foundation upon which D2C programs 
rest, and other studies have taken more progressive steps towards provider 
inclusivity.21,32,33,39,59,60  Within the Houston/Harris County program, the separation of HIV 
prevention and care services by City and County governing bodies is a significant hurdle towards 
similar approaches, but the foundational partnerships established in this study are a valued 
achievement.  These partnering providers often lack dedicated staff to identify and refer PLWH 
to the HHD, and their systems might not be easily adaptable for this purpose, requiring 
significant manual effort without outside assistance, support, or other allocated resources.  The 
mechanism for referral to the HHD was via paper, sometimes extracted by hand, making 
prioritization of these lists for surveillance investigation difficult.  Resource support for 
providers and/or emphasizing more restrictive criteria might improve the quality of these lists 
and relinkage to care outcomes.  Additionally, the SL Program might leverage unique qualities of 
providers, such as their ability to identify persons loosely engaged with care, marked by 
repeatedly missed/canceled appointments or high viral loads despite antiretroviral treatment, and 
open a new referral system for this at-risk population, although refinement of this definition 
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might prove challenging.61  Capturing persons before they are lost to the system completely by 
falling out of care would improve health outcomes for PLWH and assist each institution with 
achieving programmatic goals.   
One potential, immediate possibility for improved provider-health department relations is 
the HHD’s prospective role in fulfilling necessary standards of care, an avenue worth exploring.  
Ryan White Part A requires documentation of three attempts by more than one method to contact 
clients, a critical component of medical case management.26  Operating under respective regional 
administrative codes and the guidance of state health authorities, health departments might be 
able to alleviate this burden through D2C follow up by reporting aggregate or individually-based 
outcomes to the original referring provider, a bilateral information exchange undertaken by other 
D2C programs.21,32,39  Studies have demonstrated that reminder telephone calls reduce missed 
appointments, but some clinics had difficulty following up with patients solely via this method 
due to disconnected phones, with the percent disconnected as high as 50%.62,63 The SL Program 
can leverage greater locating data through surveillance investigation and larger outreach 
resources beyond the telephone.  This expanded partnership would strengthen services to the 
HIV community and create more possibilities to understand persons at-risk and potentially most 
receptive to targeted interventions such as described here.   
Laboratory results from hospitals, if they were CD4+ T-lymphocyte count and/or viral 
loads, counted as care for this study, but hospital networks are poor markers for health outcomes 
given they are not a primary HIV medical home, yet they might provide an opportunity for HIV-
care reengagement.  Louisiana is a remarkable example of a bidirectional, public-health 
information exchange leveraging the strengths of a state-wide, relinkage-to-care effort.  
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Combining the best of two worlds, provider networks and active referrals, it was designed to 
produce real-time provider alerts when PLWH lacking any CD4+ T-lymphocyte count/viral load 
monitoring within the past 12 months seek non-HIV related care in their integrated delivery 
network.64,65  This alert permits immediate relinkage to HIV specialty care.  Within two years, 
alerts were received across 60 clinics, 223 clinics, and 7 facilities for 419 out-of-care PLWH, of 
which 76% were once in care previously, and 85% of those persons had at least one CD4+ T-
lymphocyte count/viral load result during follow up.64,65  This program, implemented in a 
Southern environment, suggests there is an opportunity to capture persons lost to care while they 
are actively seeking medical treatment for other conditions, with elements potentially applicable 
in the Houston area. 
This study was distinct in its analysis of differences between persons qualifying for 
follow up and those who had recent evidence of care, an attempt to understand if there were 
certain characteristics associated with a critical measure of interest, the truly out-of-care 
population.  Associations were similar to the analyses among persons qualifying for follow up, 
which was not unexpected given the majority of persons who did not qualify for follow up did so 
because of recent evidence of care.  The only newfound relationship was the significance of 
persons with no viral load at last report having less odds of having recent evidence of care, which 
might indicate that persons without these laboratory measures are more likely to abstain from 
care. However, other factors could easily be influencing this measure as well, like faulty 
reporting, none of which are known.  Future analyses might implement multinomial logistic 
regression to determine if there are differences across dispositions, should they exist. 
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Results of this study support eHARS as the most comprehensive HIV care system for the 
HHD, with 84.2% of evidence of care found in this database during surveillance investigation, 
exclusively 63.0% of the time.  Selecting potentially out-of-care persons from this source is 
reasonable but likely needs adjustments in parameters as its major weakness is reporting lag-time 
and lack of real-time participant selection.  Buchacz and colleagues found about 25% of 
originally presumed out-of-care persons extracted from eHARS had altered eligibility upon re-
investigation 12 months post-initiation date, emphasizing the impact of reporting delays.21  
Although the HHD continues to improve timeliness and efficiency of HIV-case reporting 
through provider education, electronic laboratory reporting through expansion of HEDSS 
(Maven), data system integration, and routine review of internal processes and protocols, delays 
remain an issue.66,67 Future analyses can perform an assessment of eHARS surveillance referrals 
using the laboratory specimen date and reporting date to determine if the difference in time 
within the HHD system was potentially impactful.  Careful consideration of the HHD’s usage 
might entail the decree of some sort of buffer period to account for these delays, similar to the 
original CDC recommendations to account for reporting delays when performing trend analyses 
prior to significant advances in data management and bioinformatics.68  Despite the identification 
of each data systems’ usefulness, acting alone and in conjunction, data system integration would 
eliminate the labor costs of manual surveillance investigations and create more actionable 
processes.69   
The HHD might produce the surveillance list at increased intervals (e.g., biannually, 
quarterly, etc.) to avoid data expiration.  As the HHD has demonstrated, prioritization will 
continue to be necessary because the number of potentially out-of-care persons will far exceed 
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the manpower and resources available to public health institutions.  Viral suppression and a low 
CD4+ T-lymphocyte count might be one consideration for ranking priority referrals.  Viral 
suppression at last report was associated with qualifying for follow up services while having a 
last reported CD4+ T-lymphocyte count <200 cells/µL was marginally associated with relinkage 
to care.  One study found patients were more likely to return to care on their own if they had a 
suppressed viral load.70  Recent D2C demonstration projects reflect these results through 
incorporation of CD4+ T-lymphocyte count and viral load laboratory results as part of their 
eligibility criteria, emphasizing that persons with low CD4+ T-lymphocyte counts or 
unsuppressed viral loads were prioritized or considered for inclusion.21,39  This inversely begs the 
question of whether persons with suppressed viral loads and/or high CD4+ T-lymphocyte counts 
at last report are possibly lower priority.  The HHD cannot access AIDS Drug Assistance 
Program records, meaning no data is available regarding prescription distribution, negating any 
ability to assess its effect on care indicators.  Others have noted that, although the absence of 
care over a defined interval is the current standard of lost to care, patients without care >12 
months are often found to be virally suppressed, indicating a portion of this population almost 
certainly continues treatment of some manner.32 Access to prescription- level data could have led 
to their initial omission from D2C programs, reducing the number of persons with recent 
evidence of care via surveillance investigation or self-reported care to the SLWs, increasing the 
sample size and reducing resource expenditure.  
The relinkage to care program yield was low.  Even after exhausting health department 
data system resources (n=381, 35.1%), the majority of persons were still unable to locate (n=157, 
41.2%) and few were relinked to care (n=31, 8.1%).  Of those located (n=193), the majority self-
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reported already being in care (n=90, 46.6%) or refused SLW services once located (n=59, 
30.6%).  Unable to locate and/or refusal of services also made it difficult to collect information 
about the reasons for being out of care, although the top 5 reported reasons after unknown 
included feels good/was health at last doctor appointment, unfriendly care setting, does not 
want/need HHD services, does not believe HIV test results, has private/other insurance and does 
not need ancillary services.  Being a no show at scheduled intakes and/or medical appointments 
remains a significant hurdle to collecting data from this population, requiring changes in 
methodology or other alternatives to data collection.70  A reciprocal but critical relationship 
exists between a person’s engagement with other stages of the Care Continuum and being out of 
care.  In the 2011 Houston Needs Assessment, the most common reason for seeking an HIV 
diagnostic test among PLWH was “feeling sick,”2 inverse to the third leading cause of being out 
of care as reported in this study which was “feels good/was health at last doctor appointment.”  
This result might be more common in Houston and highlights the discordant nature of care 
delivery and inadequate public health messaging.  Other studies have not replicated a perceived 
lack of need for HIV care as an access barrier in a state with near universal healthcare delivery.71   
The 2011 Houston needs assessment and other jurisdictions have likewise documented 
similar barriers to care as reiterated in . 
Table 20, such as long wait times, difficulty making/keeping appointments, and problems 
with paperwork.2,71  Notably, a D2C study in Seattle/King County and the Houston Area 
Comprehensive HIV Prevention and Care Services Plan for 2012-2014 found substance abuse, 
homelessness/lack of stable housing, and variations of does not want HIV medication/doctor to 
be conspicuously high reasons for having fallen out of care. PLWH in Houston reported the two 
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most needed core HIV services were primary care (94%) and case management (84%), 
respectively, yet 93% stated primary care was accessible and 88% stated case management was 
accessible, each within the top five accessible services. Considering a lack of case management 
has been significantly associated with being out of care in some studies, as well as ancillary-
specific conditions such as mental health or substance abuse services, more local research is 
needed.72  The diversity in answers and difficulty in reaching this population to begin with create 
a significant and continuing gap in knowledge about HIV care accessibility, which might be 
confined to each jurisdiction.  This study takes a step in the first direction, but larger samples and 
expanded needs assessments are needed.  
The major strength of this study was the randomized, non-intervention group to assess 
differences between persons assigned to an SLW versus persons relinked to care on their own, 
but the sample size was small and diminished further by initial surveillance investigation 
eliminations, reducing effect size and power.  Furthermore, original sample size calculations 
estimated a large odds ratio which can only detect large effects, a shortcoming in practice, yet a 
valuable lesson learned about the need for cross-jurisdictional data sharing about D2C program 
results for improved methodology design and implementation.  This study contributed important 
knowledge by providing some of the first estimates of persons who return to care on their own. 
Among the randomized subgroups, participants in the intervention were about half as likely to be 
relinked to care by an SLW compared to those who returned to care on their own without the 
intervention, although results were insignificant (P-value>0.05).  The absence of any impact of 
relinkage-to-care programs has been replicated in the few other studies with control groups.  One 
study out of in a Seattle clinic designed a historical control group and found that time to 
85 
 
relinkage was significantly shorter among persons in the intervention group and had higher 
relinkage rates in the intervention arm (15% vs. 10%), but this study had a year follow up period 
which included relinkage to care with different measures of direct intervention assistance when 
compared to this study.32  A cluster-randomized evaluation of another D2C initiative found no 
difference between persons relinked to care and/or achieving viral suppression, with almost half 
of their initial study population returning to care prior to attempted intervention contact.39  
Researchers noted the lack of the control group in previous D2C studies might have led to false 
perceptions of the effectiveness of D2C programs as originally reported, a conclusions this study 
appears to support.39   
Similar to the immediately aforementioned studies, our study found 46.6% of persons 
contacted by SLWs self-reported already being in care, and given the non-intervention group was 
dependent upon persons returning to care on their own, it is possible that excluding persons self-
reporting being in care from the intervention group during the final analyses might impact the 
final relationship of interest.  However, given the circumstances, they were not relinked by the 
SL Program, and it was not possible to determine if/when these persons might have truly 
returned to care, nor was second surveillance investigation performed to confirm their current 
care status.  Future studies might consider alternative approaches to overcome this quandary. 
This study employed a combination of surveillance-based, clinic-based, and internal-
based referral sources to identify initially presumed, out-of-care persons, which uniquely allowed 
for a comparison of potential differences between these sources in their D2C abilities.  
Consistently, active referral sources, such as DIS-initiated or incoming OOJ referrals, had greater 
odds of qualifying for SL follow up and successful relinkage to care.  Unfortunately, this 
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mechanism also produced the fewest incoming participants, so health departments might 
consider leveraging their programmatic strengths to increase the availability of active referral 
sources and efficiency of their use.  Future programs might explore internal mechanisms 
afforded by their own health departments, given existing and easily modifiable trainings, STD 
clinical resources, educational resources, and established community relationships.   
Although race and ethnicity was not significantly associated in final analyses with 
outcomes of interest, other studies have found relationships with race/ethnicity and relinkage to 
care, with one particularly noting non-white PLWH were associated with greater likelihood of 
care reengagement.59,73 Evaluation of the HIV Care Continuum at the national level has 
demonstrated that persons of color, particularly black, are disproportionately impacted by the 
HIV epidemic.56,74  Within the black population, similar trends emerge regarding the 
discrepancies of age, with younger populations being less likely to link to care, achieve retention, 
and reach viral suppression, suggesting trends might be different with further research and better 
sampling.56  This study also lacked complete data on transmission risk category and any data 
regarding sexual orientation and gender identity (SOGI), highlighting the limitations of existing 
data systems to properly collect and report this information, rendering these vulnerable 
populations invisible to public health analysis and potential outreach.  As of 2015, a nationwide 
call to action was initiated by the Centers for Medicare and Medicaid Services under the 
Meaningful Use program to update electronic health record systems with SOGI data 
parameters,75,76 and as of 2016, the Health Resources and Services Administration has mandated 
SOGI data collection and reporting for improved outcome measures.77  Additional covariates of 
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interest would strengthen understanding of the influencers on successful follow up and care 
reengagement. 
Future studies might quantify the cost of service linkage outreach as a monetary measure.  
Colleting the total minutes spent on the phone during each call attempt could produce a 
cumulative time unit which could be assigned a labor cost/minute.  The time spent traveling to 
each field address could also be assessed for the same unit output.  Furthermore, the City of 
Houston assigns a pre-designated mileage allocation for travel reimbursement.  It is possible to 
geocode the addresses and determine the total distances traveled by SLWs in their attempts to 
contact potential out-of-care clients in addition to the cost of these outreach attempts and analyze 
the yield in terms of relinkage success.78,79  Additionally, stratifying these results by the 
significant variables in these analyses might help determine if there are variations in certain 
variables and determine if specific sub-populations are harder to reach and might need more 
tailored approaches.  Contact attempts should also not just be limited to phone and field visits but 
additional expansion to emails and text messages, as successful pilot programs built around 
linkage, relinkage, and retention have been initiated with additional follow up needed.78 
Additional limitations of the current study include using time since HIV diagnosis as a 
proxy for age given it eliminates a true measure for this variable, but using this measure 
strengthens the assumptions of the multivariable logistic regression model, the benefits outweigh 
the potential loss of data.  Categorization of continuous variables results in some loss of 
information and loss of power, but the only variables retained permanently in the final analyses 
in their categorical format were most recent CD4+ T-lymphocyte count and most recent viral 
load laboratory result, and there was strong clinical and public health justification for this 
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action.80  Confounding factors are of potential concern, and additional literature is needed.81  
Limitations of the Firth penalized likelihood method include potential upwards bias.82  However, 
given that the Firth method offsets the restrictions of small sample sizes when using maximum 
likelihood estimation in multivariable logistic regression analyses, the statistical gain overcomes 
the primary weakness of the data.  Additionally, given the exploratory nature of this pilot project, 
much was learned about the lower than expected proportion of the outcome of interest, i.e., 
relinkage/return of PLWH to care, including both practical lessons learned and statistical 
implications for recreating similar randomized interventions to determine if trends are repeatable.  
More efforts are needed to enroll persons for larger samples sizes and more time might be 
needed to allow for proper population estimates to occur.  List-wise deletion of missing variables 
might be biased with better methods available for handling these data, yet missing data were 
small (<5%) and limited to few analyses, thereby minimizing its impact, if any.83  
CONCLUSION 
 
Health departments contribute key information about the out-of-care population, but 
these systems fall short in timeliness and completeness when it comes to producing the necessary 
information needed to successfully contact this hard to reach population, requiring extensive 
resource input and management.  More information is needed about their reasons for falling out 
of care to better assess their specific needs and the dynamics influencing the fluid nature of HIV 
care in order to capture this population before they are lost from the medical system.   
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APPENDICES 
 
Appendix A. List of Definitions 
 
Administratively Closed – Outcomes assigned via record searches only as determined by data 
system information and not assigned to the intervention (i.e., the SL Program).  Both the initial 
cohort and the intervention subgroups could be administratively closed. 
Qualified for SLW Assistance – Referrals without a surveillance investigation outcome from 
online record searches qualified for the intervention (i.e., outreach by an SLW).  These persons, 
upon completion of the first surveillance investigation among the care and laboratory data 
systems, did not have evidence of care in the immediate six months prior to the date of the 
investigation and were presumed to be out of care.  They also lacked evidence of any other 
outcome such as incarceration, death, out of jurisdiction, etc.  Non-intervention subgroup 
members could also have database evidence of being truly out of care with no other outcome 
based on the set parameters during the first surveillance investigation timeframe, but they were 
never officially assigned to SLW assistance. 
Intervention Subjects – A subgroup of incoming referrals from the surveillance (eHARS) referral 
source.  The eHARS referrals were randomly assigned an intervention or non-intervention status.  
Intervention subgroup members were non-distinct from the other referrals in the study except for 
their respective non-intervention arm.  They were record searched in the same timeline as the 
other study subjects, excluding the non-intervention subgroup, and assigned to the SLWs using 
the same criteria for inclusion.  
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Non-intervention Subjects – A subgroup of incoming referrals from the surveillance (eHARS) 
referral source.  The eHARS referrals were randomly assigned an intervention or non-
intervention status.  Non-intervention subgroup members were managed by the same initial 
surveillance investigation criteria and timeline.  However, if a non-intervention subject was 
confirmed to be out of care, it was not assigned to an SLW.  Instead, surveillance investigation 
would re-occur after a 90-day period to determine if the non-intervention subject returned to care 
without SLW intervention for comparison to the intervention members who were assigned to an 
SLW for assistance with returning to care. 
Surveillance Investigation (SI) – Electronic record searches among HIV care, surveillance, and 
public records data systems to assess the following outcomes: evidence of care, incarcerated, 
deceased, ineligible, or out of care within the previous six months.  This step determined if 
incoming referrals were currently considered out of care per available data systems and would 
subsequently be assigned to an SLW and/or additional surveillance investigation if the referral 
was assigned to the non-intervention subgroup. 
Out of Care – A referral was determined to be out of care when there was no evidence of a CD4+ 
T-lymphocyte count and/or viral load laboratory result and/or HIV care appointment within the 
previous six months of a surveillance investigation date.  An incoming referral should have been 
out of care for at least six months prior to the referral date (i.e., the date the referral was received 
by the HHD) according to the referral source’s internal record system. 
CD4+ T-lymphocyte count - A CD4+ T-lymphocyte count is a measure of the number of CD4+ 
cells (aka T-helper cells) in a sample of blood. A simple blood test can count the cells. CD4+ 
cells are a type of immune system cell in the body that HIV attacks and kills over time. It is 
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considered a proxy of HIV care because a person’s CD4+ T-lymphocyte count increases as the 
HIV virus is controlled through adherence to treatment and consistent medical care.84,85  
Therefore, conducting regular CD4+ T-lymphocyte count tests is considered a standard of HIV 
care because it is a marker of a PLWH’s current health status.85–87 
Viral Load – A viral load is the amount of virus in the blood. It is measured by a simple blood 
test.  Like a CD4+ T-lymphocyte count, treatment adherence influences a person’s viral load by 
decreasing it to undetectable levels, serving as an indicator of consistent medical care.84,85  
Therefore, conducting regular viral load tests is considered a standard of HIV care because it is a 
marker of a PLWH’s current health status.85–87 
Service Linkage Worker (SLW) – SLWs are a type of non-medical case manager who, for the 
purposes of this study intervention, contacted HIV-infected persons not currently receiving 
medical care who were once in HIV care and facilitated the return of these persons to care.  
Service Linkage (SL) Program – The SL Program houses the SLWs.  In existence before the 
implementation of this study, it was originally designed to assist with initial linkage to care for 
newly diagnosed, HIV-positive persons.   
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Appendix B. Logistic Regression Model 
π(𝑥) =
𝑒𝑥′𝛽
(1 + 𝑒𝑥
′𝛽)
 
 
 
π(𝑥) is the probability of a Bernoulli random variable which takes the value 1 or 0 evaluating at  
a covariate matrix x, and 𝛽 is the parameter vector48 
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Appendix C. Firth correction: estimates 𝛽 as the maximum of the penalized loglikelihood 
ℓ∗ (𝛽) = ℓ(𝛽) +
1
2
𝑙𝑛|𝐼(𝛽)| 
 
ℓ(𝛽) is the model loglikelihood, ½ln|I| is the penalty term48–50,82  
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Appendix D. SAS 9.4 software code for Aim 1 multiple logistic regression results in Table 12 
and associated diagnostics 
 
proc logistic data=FULL2 order=data; 
   class Merck2 (ref="NO" param=ref) TAB3 (ref="PROV" param=ref) VL4 
(ref="suppressed" param=ref) CD44 (ref="greater200" param=ref); 
   model Merck2=HIV2 TAB3 VL4 CD44 /  selection=backward fast slstay=0.2 
ctable lackfit rsq; 
run; 
 
ods graphics on; 
proc logistic data=FULL2 order=data; 
   class Merck2 (ref="NO" param=ref) TAB3 (ref="PROV" param=ref) VL4 
(ref="suppressed" param=ref) CD44 (ref="greater200" param=ref); 
   model Merck2=HIV2 TAB3 VL4 CD44 / lackfit rsq TECHNIQUE=NEWTON OUTROC=ROC 
CLPARM=WALD CLODDS=WALD 
     SCALE=NONE PPROB=0.5 CTABLE NODUMMYPRINT NOLOGSCALE NOCHECK; 
  OUTPUT OUT=pred RESDEV=resdev RESCHI=reschi H=hat p=phat 
lower=lcl upper=ucl PRED=pred PREDPROB=(individual crossvalidate); 
   effectplot slicefit; 
run; 
 
ods graphics on; 
proc univariate data=pred; 
 histogram resdev reschi / 
  NORMAL (COLOR=red W=3 
  PERCENT=20 40 60 80 
  MIDPERCENTS) CFILL= blue 
  CFRAME= yellow; 
RUN; 
 
ods graphics on; 
proc loess data=Test; 
      model Merck3=HIV2/smooth=0.1 0.25 0.4 0.6 residual; 
      ods output OutputStatistics=Results; 
run; 
 
proc loess data=Test; 
   model Merck3=HIV2 / details(ModelSummary OutputStatistics); 
run; 
 
proc reg data=Test; 
 model Merck3=HIV2 TAB5 VL CD4 / vif tol collin; 
run; 
 
proc corr data=Test spearman; 
 var AGE6 TAB5 VL CD4; 
run; 
 
proc corr data=Test pearson; 
 var HIV2 AGE2; 
run; 
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Appendix E. SAS 9.4 software code for Aim 1 multiple logistic regression results in Table 17 
and associated diagnostics 
 
proc logistic data=care order=data; 
   class DISPO3 (ref="outofcare" param=ref) TAB3 (ref="PROV" param=ref) VL4 
(ref="suppressed" param=ref); 
   model DISPO3=HIV2 TAB3 VL4 / selection=backward fast slstay=0.2 ctable 
lackfit rsq; 
run; 
 
ods graphics on; 
proc logistic data=care order=data; 
   class DISPO3 (ref="outofcare" param=ref) TAB3 (ref="PROV" param=ref) VL4 
(ref="suppressed" param=ref); 
   model DISPO3=HIV2 TAB3 VL4 / lackfit rsq TECHNIQUE=NEWTON OUTROC=ROC 
CLPARM=WALD CLODDS=WALD 
     SCALE=NONE PPROB=0.5 CTABLE NODUMMYPRINT NOLOGSCALE NOCHECK; 
  OUTPUT OUT=pred RESDEV=resdev RESCHI=reschi H=hat p=phat 
lower=lcl upper=ucl PRED=pred PREDPROB=(individual crossvalidate); 
   effectplot slicefit; 
run; 
 
ods graphics on; 
proc loess data=Test2; 
      model DISPO=HIV2/smooth=0.1 0.25 0.4 0.6 residual; 
      ods output OutputStatistics=Results; 
run; 
 
proc loess data=Test; 
   model DISPO=HIV2 / details(ModelSummary OutputStatistics); 
run; 
 
proc reg data=Test2; 
 model DISPO=HIV2 TAB5 VL / vif tol collin; 
run; 
 
proc reg data=Test2; 
 model DISPO=HIV2 AGE6 TAB5 VL / vif tol collin; 
run; 
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Appendix F. SAS 9.4 software code for Aim 2 multiple logistic regression results in Table 23 
and associated diagnostics 
 
proc logistic data=SLWonly order=data; 
   class SLWDISPO2 (ref="Other" param=ref) TAB3 (ref = "PROV") CLIENT_PCS 
(ref = "2orless") RACE2 (ref = "W") PROV_PCSS (ref = '0') 
     PROV_FVS (ref = "0") CD44 (ref="greater200" 
param=ref)/ param=ref; 
   model SLWDISPO2=RACE2 TAB3 CD44 CLIENT_PCS / firth clodds=pl lackfit rsq; 
   effectplot; 
run; 
 
ods graphics on; 
proc logistic data=SLWonly order=data; 
   class SLWDISPO2 (ref="Other" param=ref) TAB3 (ref = "PROV") CLIENT_PCS 
(ref = "2orless") RACE2 (ref = "W") PROV_PCSS (ref = '0') 
     PROV_FVS (ref = "0") CD44 (ref="greater200" 
param=ref)/ param=ref; 
   model SLWDISPO2=RACE2 TAB3 CD44 CLIENT_PCS / firth clodds=pl lackfit rsq 
TECHNIQUE=NEWTON OUTROC=ROC CLPARM=WALD CLODDS=WALD 
     SCALE=NONE PPROB=0.5 CTABLE NODUMMYPRINT NOLOGSCALE NOCHECK; 
  OUTPUT OUT=pred RESDEV=resdev RESCHI=reschi H=hat p=phat 
lower=lcl upper=ucl PRED=pred PREDPROB=(individual crossvalidate); 
   effectplot slicefit; 
run; 
 
ods graphics on; 
proc univariate data=pred; 
 histogram resdev reschi / 
  NORMAL (COLOR=red W=3 
  PERCENT=20 40 60 80 
  MIDPERCENTS) CFILL= blue 
  CFRAME= yellow; 
RUN; 
 
proc reg data=Test2; 
 model DISPO=TAB5 RACES CD4 C_PCS / vif tol collin; 
run; 
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Appendix G. SAS 9.4 software code for Aim 2 multiple logistic regression results in Table 26 
and associated diagnostics 
 
proc logistic data=SLWonly order=data; 
 class SLWDISPO5 (ref="UnabletoLocate" param=ref) TAB3 (ref = "PROV") 
CLIENT_PCS (ref = "2orless") CLIENT_FVS (ref = '0') 
         VL5 (ref = 'suppressed') / param=ref; 
    model SLWDISPO5= HIV2 TAB3 VL5 CLIENT_PCS CLIENT_FVS  / firth clodds=pl 
lackfit rsq; 
 effectplot; 
run; 
 
ods graphics on; 
proc logistic data=SLWonly order=data; 
    class SLWDISPO5 (ref="UnabletoLocate" param=ref) TAB3 (ref = "PROV") 
CLIENT_PCS (ref = "2orless") CLIENT_FVS (ref = '0') 
         VL5 (ref = 'suppressed') / param=ref; 
    model SLWDISPO5=TAB3 VL5 CLIENT_PCS CLIENT_FVS / lackfit rsq 
TECHNIQUE=NEWTON OUTROC=ROC CLPARM=WALD CLODDS=WALD 
     SCALE=NONE PPROB=0.5 CTABLE NODUMMYPRINT NOLOGSCALE NOCHECK; 
  OUTPUT OUT=pred RESDEV=resdev RESCHI=reschi H=hat p=phat 
lower=lcl upper=ucl PRED=pred PREDPROB=(individual crossvalidate); 
   effectplot slicefit; 
run; 
 
ods graphics on; 
proc univariate data=pred; 
 histogram resdev reschi / 
  NORMAL (COLOR=red W=3 
  PERCENT=20 40 60 80 
  MIDPERCENTS) CFILL= blue 
  CFRAME= yellow; 
RUN; 
 
ods graphics on; 
proc loess data=Test2; 
      model DISPOS2=HIV2/smooth=0.1 0.25 0.4 0.6 residual; 
      ods output OutputStatistics=Results; 
run; 
 
proc loess data=Test2; 
   model DISPOS2=HIV2 / details(ModelSummary OutputStatistics); 
run; 
 
proc reg data=Test2; 
 model DISPOS2=TAB5 VL C_PCS C_FVS / vif tol collin; 
run; 
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Appendix H. SAS 9.4 software code for Aim 3 multiple logistic regression results in Table 32 
and associated diagnostics 
 
proc logistic data=Final3 order=data; 
 class FINALDISPO ORIGIN (ref='90DAYONLY') ETH (ref='NH' param=ref) AGE5 
(ref='44orless' param=ref); 
 model FINALDISPO=ORIGIN ETH AGE5 / firth clodds=pl lackfit rsq; 
 effectplot; 
 where Merck='YES'; 
run; 
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Appendix I. SAS 9.4 software code for Aim 3 multiple logistic regression results in Table 33 and 
associated diagnostics 
 
proc logistic data=Final3 order=data; 
 class FINALDISPO ORIGIN (ref='90DAYONLY'); 
 model FINALDISPO=ORIGIN/ firth clodds=pl lackfit rsq; 
 effectplot; 
 where Merck='YES'; 
run; 
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